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Abstract
Protein bodies (PBs) are endoplasmic reticulum (ER) derived organelles found in seeds
whose function is to accumulate seed storage proteins. It was shown that PB formation is not
limited to seeds, and green fluorescent protein (GFP) fused to either elastin-like polypeptide
(ELP), hydrophobin-I (HFBI) or Zera® fusion tags induces PBs in leaves of Nicotiana
benthamiana. The mechanism by which fusion tags induce PBs is not well understood. To
address how PBs form and develop in plant leaves, I studied the factors involved in their
formation including recombinant protein concentration, effect of the fusion tags, PB
sequestration patterns and destination in vivo.
In this study I showed that PB formation is a concentration-dependent mechanism and that
proteins accumulating at levels higher than 0.2% of total soluble protein are capable of
inducing PBs in vivo. The presence of fusion tags is not necessary for the formation of PBs
but affects their distribution pattern and size. ELP-induced PBs are larger than HFBI-induced
PBs and the size of both PBs increases over time along with accumulation levels of the
recombinant protein. I found that in the process of PB formation, secretory and ER resident
molecules are passively sequestered into the lumen of PBs. This property of PBs was
proposed as a tool to increase accumulation levels of erythropoietin and human interleukin10 by co-expression with PB-inducing proteins. To understand whether PBs are terminallystored cytosolic organelles or if they are connected to the ER and to each other, I developed
an EGFP-based photoconversion technique, which was successfully used to visualize the
trafficking of proteins targeted to the cytosol, ER, apoplast, and chloroplast in vivo. Study of
PBs with this technique suggested that PBs remain associated with the ER and communicate
with one another via the ER.
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General Introduction
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1.1 Plants as bioreactors
During the past two decades, recombinant protein production in plants has gained
popularity over other conventional methods. Plants are now considered as a safe, efficient
and inexpensive platform for production of a wide range of recombinant proteins
including enzymes, vaccines, antibodies and other biopharmaceuticals (Gutiérrez and
Menassa, 2014). In 2012, the first plant-produced therapeutic protein, taliglucerase alfa,
for treatment of Gaucher disease was approved by the US Food and Drug Administration
(Maxmen, 2012).
The second success story was recently reported upon the outbreak of Ebola. ZMapp™, a
cocktail of three monoclonal antibodies produced in transgenic Nicotiana benthamiana is
so far the only treatment successfully used against the Ebola virus. This cocktail
combination was tested on infected Rhesus monkeys and 100% of the animals recovered
(Qiu et al., 2014). Even though ZMapp™ was produced by collaboration of three
biotechnology companies (Mapp Biopharmaceutical Inc. (San Diego), LeafBio (San
Diego), Defyrus Inc. (Toronto)), and the public health agency of Canada and the defense
advanced research project agency (DARPA) of the U.S.A., the cocktail was only enough
for treatment of six individuals, and another 50 treatment courses are expected to be
produced by the end of 2014 (Strauss, 2014).
Although successful cases of plant-produced recombinant proteins are gradually
emerging, plant biotechnology still faces two serious challenges: low production yield
and lack of efficient purification methods that need to be addressed. To achieve the
highest levels of recombinant protein production in plants, several factors should be taken
into consideration, such as the expression system, the target tissue and the subcellular
location for production of the protein of interest (Twyman et al., 2013).
Currently, several types of plant expression systems are available for production of
foreign proteins, which include transgenic plants with either nuclear or chloroplast
transformed genomes, cell suspension cultures and transient expression. Similarly,
recombinant proteins have been targeted to a wide range of subcellular locations such as
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the ER, the apoplast, the cytosol and the chloroplast to optimize their expression and
accumulation levels. Each one of these categories is explained in the following sections.

1.1.1

Nuclear transformed plants

Biological and physical methods can be used to transfer foreign DNA into a plant cell.
The most studied biological method is Agrobacterium-mediated transformation.
Agrobacterium tumefaciens is a soil microorganism that causes crown gall disease in
many species of dicotyledonous plants (Shrawat and Lörz, 2006) and is well known for
its ability to infect plants with a tumor-inducing (Ti) plasmid. A remarkable feature of the
Ti plasmid is that, after infection, part of the plasmid molecule, called T-DNA, integrates
into the plant chromosomal DNA (Zhu et al., 2000). This strategy can be used to
integrate any foreign gene into the T-DNA and infect the cells with the Agrobacterium
containing the recombinant plasmid (Gelvin, 2003). Since Agrobacterium-mediated
transformation is more successful in dicots than in monocots, other transformation
methods are required to address the need for transforming monocot plants. Such methods
are usually based on physical delivery of the genes into the plant cells.
Direct gene transfer via microprojectile bombardment (biolistics), polyethylene glycol
(PEG) mediated transformation, electroporation, and inoculation following abrasion of
the surface are examples of physical transfer of DNA into plant cells (Rao et al., 2009).
Biolistic delivery is the most common physical approach for introduction of a transgene
into the nuclear genome of a host plant (Sanford et al., 1987). A “gene gun” is usually
used to shoot gold or tungsten particles, coated with “naked DNA”, into plant cells. This
method has been successfully applied on a wide range of crops especially monocots such
as wheat and maize (Shrawat and Lörz, 2006).
The prominent advantage of nuclear transformation of plants is their flexibility and
efficiency in scaling up the production of recombinant proteins. Additionally, since
foreign genes are integrated into the nuclear genome of plants, they can be inherited over
generations which accounts for stable and predictable transgene expression in several
generations (Egelkrout et al., 2012).
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On the other hand, nuclear transformation requires relatively long periods of time
(approximately 6 to 9 months) to generate transgenic plants and select for lines producing
high levels of recombinant proteins. Also, biosafety concerns are raised with transgenic
plants due to the risk of gene leakage through cross pollination and seed mixing with wild
type plants (Andow and Hilbeck, 2004; Breyer et al., 2012). Since the integration of the
T-DNA happens in a random fashion into unpredictable locations within the plant
genome, expression levels may vary between different transformants (also known as
“positional effect”). As a result, nuclear transformed plants generally provide low
accumulation levels of recombinant proteins, which usually fall within the range of
0.001% to 1% of the total soluble protein (TSP) (Lossl and Waheed, 2011).

1.1.2

Chloroplast transformed plants

Integrating a transgene into the chloroplast genome carries two major advantages when
compared with nuclear transformed plants: first, accumulation levels of the recombinant
proteins are generally higher in transplastomic plants (plants whose chloroplast genome
is transformed); second, since in most angiosperms plastids are inherited in a maternal
fashion, it is highly unlikely that the foreign DNA will be transmitted through pollen
which reduces the risk of gene flow from genetically modified plants to others (Maliga
and Bock, 2011; Ruf et al., 2007).
Chloroplast transformation is an attractive candidate for expression of a transgene since
every chloroplast contains approximately 100 identical genomes and a typical plant leaf
cell contains about 100 chloroplasts. Therefore, by transforming chloroplasts, a single
gene can be represented up to 10,000 times within one cell. Considering this major
advantage, it is not unusual to see accumulation levels of 5% to 20% of TSP in
transplastomic plants (Chebolu and Daniell, 2009; Svab et al., 1990). Unlike the random
integration of the T-DNA in nuclear transformation which results in variable expression
of the transgene, incorporation of the transgene occurs accurately through homologous
recombination in chloroplasts. This precise integration of the transgene reduces laborintensive and time-consuming screening steps required for selecting high expressing
plants produced by nuclear transformation (caused by positional effects). Lack of
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transgene silencing is another advantage of chloroplast expression systems in addition to
the accumulation of transcripts at high levels compared with nuclear transgenic plants.
Moreover, chloroplast transformation includes the ability of expressing several genes
simultaneously (transgene stacking), and the ability to perform the complex posttranslational modifications including disulfide bond bridging, protein lipidation, folding
and assembly of recombinant proteins (New et al., 2012; Verma and Daniell, 2007).
However, chloroplast transformation has its own limitations. Because of their prokaryotic
endosymbiotic origins, chloroplasts have prokaryotic transcription and translation
machineries and as such, they are unable to perform glycosylation which is necessary for
many pharmaceutical glycoproteins such as monoclonal antibodies (Hefferon, 2013). So
far, plastid transformation has been more successful in dicots and has remained limited to
a few plant species such as tobacco, tomato, and lettuce (Clarke and Daniell, 2011).

1.1.3

Plant cell suspension cultures

Plant cell suspension cultures have the same advantages of whole plant cultivation, and
also offer advantages found in microbial and animal cell cultures. This includes rapid
doubling times, easy scale-up, post-translational modifications and product safety.
Moreover, recombinant proteins produced in plant cell suspension cultures display better
consistency than over other plant expression systems. This is mainly because of the
highly controlled conditions in bioreactors leading to uniformity of cells grown in
suspension cultures (De Muynck et al., 2009). A number of good examples are tobacco
BY-2 and NT-1 cell lines which have high growth rates, and also produce highly
consistent protein products (Hellwig et al., 2004; Xu et al., 2011).
The main advantage of cell suspension cultures is their ability to secrete the recombinant
protein to the cell culture medium, which eliminates the need to break the cells, and
reduces the complexity of purification (Huang et al., 2009). However, the major
challenge for production of secreted recombinant proteins is relatively low accumulation
(Xu et al., 2011). The main reason for low accumulation levels in the cell culture medium
is degradation by secreted proteases (Schiermeyer et al., 2005). However, retaining
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recombinant proteins intracellularly has been shown to produce high accumulation levels
(Kaldis et al., 2013).

1.1.4

Transient expression

Transient expression of a foreign gene stands out in several aspects when compared with
other plant expression systems. Simplicity and ease of work, scalability, short generation
and production timelines, high recombinant protein levels and biosafety are some of the
major advantages of this expression system. To date, several breakthroughs have been
reported in transient expression that allow for achieving impressive expression levels.
These methods usually rely on two classes of plant pathogens; Agrobacterium, plant
viruses or a combination of both (Magnifection).

1.1.4.1

Agrobacterium-mediated expression

The mechanism by which Agrobacterium transformation works is explained in section
1.1.1. Once the T-DNA is trafficked to the nucleus, only a small percentage of the TDNA is integrated into the host genome which causes the formation of stable transformed
cells that can subsequently be generated into transgenic plants (Zambryski, 1988). It is
not clear what happens to the T-DNAs which do not integrate into the genome, but it has
been shown that these T-DNAs are transcriptionally competent, and therefore could be
employed for expression of the transgene for short periods of time (Voinnet et al., 2003).
By using Agrobacterium-mediated transient expression, harvesting timelines have been
reduced drastically. High yields of recombinant proteins can be achieved within 2-5 days,
making this expression system an attractive option for production of recombinant
proteins. This system is also very flexible as multiple genes can be expressed
simultaneously. Since transient expression is independent of the problems involved with
positional effects, it can be a reliable and reproducible source for transgene expression
(Kapila et al., 1997).
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1.1.4.2

Virus-based expression

Viral-based expression systems rely on the idea of using viruses as vectors to deliver
transgenes into plants. Tobacco mosaic virus (TMV) and potato virus X (PVX) are
among the most commonly used viruses for transient expression. Virus-based systems
have several advantages such as rapid delivery of the transgene and systemic infection of
the whole plant after inoculation. As a result, they produce high levels of recombinant
proteins. Plant virus-based expression systems have been used for production of several
pharmaceutical proteins such as full-sized and fragments of antibodies (Gleba et al.,
2007; Yusibov et al., 1997).
Viral expression systems have two major disadvantages: size limitations of the insert
introduced into the viral genome, and safety concerns regarding the spread of the viral
vectors into the environment (Yusibov et al., 1997). To resolve these issues, a new
system was designed by Icon Genetics, a biotechnology company, called “Magnifection”
(also known as MagnICON®). Magnifection combines the high transfection efficiency of
Agrobacterium with high expression yield of viral vectors (Gleba et al., 2005). This
method is based on a “deconstructed” TMV vector, optimized by deletion of viral
sequences responsible for replication and spreading of the virus, and split into two
modules. The first module carries the viral polymerase and the movement protein genes
while the second module includes the gene of interest. Both modules are inserted into
binary vectors and transformed into Agrobacterium. In this process, bacteria are
responsible for the primary role of infection and delivery of modules into the plant cell
nucleus. Also, a third Agrobacterium cell line is required to deliver a specific
recombinase so the modules can assemble in vivo. Since TMV-based vectors cannot
move systemically due to lack of a coat protein, production in the whole plant requires
inoculation of all leaves. This was addressed by immersing all aerial parts of the plant
into the bacterial solution (Marillonnet et al., 2005). Major advantages of the
MagnICON® system are: flexibility with the size of the transgene, inability to leak
through the plant and into the environment, and accumulation of high quantities of
recombinant protein. For instance, the company Kentucky BioProcessing (KBP) uses this
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system to produce 25-75 grams of antibody per greenhouse on a biweekly basis (Pogue et
al., 2010).

1.1.4.3

Commercial scale Agro-infiltration

Transient expression by Agro-infiltration was initially used as a rapid technique to assess
the ability and efficiency of constructs for production of recombinant proteins. For this
purpose, transformation of only a portion of the plant tissue (e.g. leaf) with a syringe
would suffice. Syringe infiltration has been used on a wide range of hosts including
Arabidopsis thaliana, Nicotiana tabacum, tomato and lettuce (Wroblewski et al., 2005).
Due to the efficiency of this method, it has been scaled up for vacuum infiltration to
fulfill the demands of the market. Vacuum infiltration enables the infiltration of the
whole plant or kilograms of the tissue at once. It has been shown that syringe infiltration
is approximately twice as efficient compared with vacuum infiltration (Vézina et al.,
2009). However, vacuum infiltration has been accepted and developed by several
biotechnology companies such as Medicago Inc., Kentucky BioProcessing, and the
Fraunhofer institute to infiltrate kilograms of plants per hour (D'Aoust et al., 2010; Pogue
et al., 2010).

1.2 Strategies to increase expression and accumulation of
recombinant proteins
1.2.1

Transcription

To ensure high levels of transcription, the most important factor is the promoter. To date,
several promoters have been developed to obtain high levels of transcripts in plants.
These promoters are usually obtained from plants or plant pathogens. Egelkrout et al.
have reviewed 84 different promoters used for protein accumulation in various plant
species (Egelkrout et al., 2012). These promoters can generally be divided into
constitutive, organ-specific and inducible promoters. Each one of these categories can be
further divided into monocot- or dicot-specific promoters. Some of the most popular
promoters are discussed in the following paragraphs.
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The cauliflower mosaic virus (CaMV) 35S promoter has been used extensively since its
discovery almost three decades ago (Gutiérrez et al., 2013; Odell et al., 1985). CaMV
35S is a strong constitutive promoter and the most popular choice for dicot plants.
However, it has a much weaker activity in monocots. To obtain high expression levels in
monocots, maize ubiquitin-1 (Christensen et al., 1992) or Agrobacterium tumefaciens
nopaline synthase (nos) (Shaw et al., 1984) promoters are better choices.
To express the transgene in a particular tissue or at a specific developmental stage, tissuespecific promoters and inducible promoters were developed. For instance, maize
globulin-1(Belanger and Kriz, 1989), globulin-2 (Hood et al., 2003) and novel
(Streatfield et al., 2010) are monocot embryo-specific promoters while maize α- and γzeins (Zhang et al., 2009), rice glutelin, globulin and prolamins (Qu et al., 2008) are
examples of endosperm-specific promoters. These promoters restrict the expression of
the foreign gene to certain tissues or areas of the seed. As a result, not only stability of the
recombinant protein increases but also the whole plant is protected against the
unfavorable effects (e.g. toxicity) of highly accumulated protein (Stoger et al., 2002).
To further increase transcript levels of a transgene, other strategies have been developed
such as incorporation of additional duplicated enhancer elements to CaMV 35S promoter.
It has been shown that the activity of double enhanced CaMV 35S promoter is
approximately 10 times stronger than the natural CaMV 35S (Kay et al., 1987). Another
strategy is to synthesize “hybrid promoters” by combining the most critical sequences of
multiple well-characterized natural promoters. Combination of critical sequences of
CaMV 35S and Agrobacterium Ti plasmid mannopine synthase promoters resulted in a
much stronger activity compared with either of the two parental promoters (Comai et al.,
1990).

1.2.2

Suppression of post-transcriptional gene silencing (PTGS)

PTGS is considered one of the plants earliest self defense mechanisms against molecular
parasites such as transposons, viruses and transgenes (Voinnet, 2001). PTGS is capable
of generating sequence-specific signals that can move from cell to cell and activate the
systemic silencing in faraway tissues which makes it an efficient antiviral system
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(Palauqui et al., 1997; Voinnet and Baulcombe, 1997). Highly expressed transgenes were
shown to be susceptible to PTGS. This mechanism requires an RNA-dependent RNA
polymerase (RdRp)-like protein to generate the complementary RNA of the target species
(Dalmay et al., 2000). Following the formation of double-stranded RNA (dsRNA), it will
be recognized and cleaved by a nuclease into 21-23 nucleotide small dsRNAs (Voinnet et
al., 1999; Zamore et al., 2000). These dsRNAs will incorporate into a conserved nuclease
protein complex called RNA-induced silencing complex (RISC) and lead the complex to
the complementary target mRNA for sequence-specific cleavage of target RNA transcript
(Voinnet et al., 1999).
Since suppression of gene silencing is critical for invading viruses, many plant viruses
have evolved silencing suppressor proteins. These proteins were shown to target different
steps of the silencing process (Qu and Morris, 2005; Voinnet et al., 1999). To avoid
PTGS, these virus-based suppressors of gene silencing can be expressed simultaneously
with the gene of interest. For instance, co-expression of a murine anti-human IgG C5-1
with HC-Pro (from potato virus Y) resulted in a 5.3-fold increase in C5-1 antibody
accumulation levels (Vézina et al., 2009). Another well-studied example of PTGS
suppressor is the tomato bushy stunt virus (TBSV) p19 protein. Co-expression of p19
along with the transgene was shown to increase accumulation levels of the target protein
up to 50-fold (Voinnet et al., 2003). Similarly, co-expression of p19 with trastuzumab, a
therapeutic antibody used in the treatment of HER2+ breast cancer, increased
accumulation levels of trastuzumab in N. benthamiana up to 15-fold (Garabagi et al.,
2012). This strategy is compatible with different expression systems and can be easily
used for both lab and industrial scale purposes.
When the p19 gene was incorporated in the same T-DNA cassette that contains the
transgene in the pEAQ vector series (Peyret and Lomonossoff, 2013; Sainsbury et al.,
2009), the result was higher levels of recombinant protein than co-infiltrating a separate
Agrobacterium culture containing p19 (Sainsbury et al., 2009).

11

1.2.3

Translation

Maintaining optimal levels of transcript does not necessarily result in high accumulation
levels of the recombinant protein. Approximately 20% to 40% of foreign protein
accumulation is directly regulated by its corresponding mRNA transcript. Factors such as
translation and degradation rates strongly influence the accumulation levels of
recombinant proteins (Nie et al., 2006). Regulation at the translational level has such
importance that in some cases it has been counted as the most critical regulator of
recombinant protein abundance. To boost the translation of foreign proteins, several
strategies have been investigated including codon optimization, and the use of transcript
untranslated regions (UTRs) (Desai et al., 2010).
Different organisms have particular codon usages which can cause problems during
translation such as pausing at disfavoured codons, and frame-shifting. Therefore, to
increase the translation efficiency of a foreign gene, codon optimization is considered a
priority, most importantly for production of prokaryotic proteins in eukaryotic expression
systems. For instance, codon optimization of a synthetic cholera toxin B (CTB) gene
based on that of tobacco resulted in approximately 15-fold increase in accumulation level
of the recombinant protein compared with the bacterial CTB (Kang et al., 2004). With
the advances in the field of bioinformatics, currently several codon usage software
packages are available online such as Gene Designer (Villalobos et al., 2006), and
Optimizer (Puigbò et al., 2007) to help scientists optimize their transgene sequences at no
cost. It is important to mention that any codon change may cause unwanted and
problematic modifications at the RNA level leading to instability at the posttranscriptional processing level. Therefore, the codon-optimized sequence should be
carefully examined for unexpected regulatory outcomes as well as possible issues with
folding and stability of the transcript (Laguia-Becher et al., 2010).
Another strategy to increase the rate of translation is to include the plant or plant viral 5’untranslated sequences into the transgene construct to increase the rate of translation
initiation. Several 5’-untranslated regions (5’-UTRs) have been studied and proved to be
effective in increasing the accumulation levels of their respective proteins such as the 5’-
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UTR of tobacco mosaic virus (Sleat et al., 1987), potato virus X (Pooggin and Skryabin,
1992), tobacco tCUP (Wu et al., 2001), and Oryza sativa alcohol dehydrogenase that was
used to increase recombinant protein accumulation in both monocots and dicots (Sugio et
al., 2008). Liu et al. (2010) have also described the role of six different 5’-UTRs of seedstorage genes in enhancing the expression of foreign genes in stable transgenic rice.

1.2.4

Optimization of protein accumulation and stability

To achieve high accumulation levels of heterologous proteins in plants not only boosting
transcription and translation are required, but also it is important to protect the produced
protein against degradation. Proteases are the main factor responsible for degradation of
heterologous proteins. Several strategies have been proposed to avoid or reduce the
effects of proteases in plants including the use of protease-deficient plants, co-expression
with protease inhibitors, targeting of the recombinant protein to a specific organelle, or
fusion to other proteins (Benchabane et al., 2008).

1.2.4.1

Proteolysis prevention via co-expression of protease
inhibitors

The major function of proteases is to degrade the incorrectly folded or abnormal proteins
to ensure the final quality of the synthesized proteins; meanwhile, proteases directly
affect the yield of foreign proteins expressed in plants (Desai et al., 2010). Proteasedeficient plants were proposed to avoid protease-mediated degradation. This strategy was
successfully developed in bacteria (Jiang et al., 2002) and yeast (Macauley‐Patrick et al.,
2005) several years ago, but as there are approximately over 1900 genes directly or
indirectly involved in the hydrolysis of peptide bonds in plants, production of these plants
is highly unlikely (Benchabane et al., 2008). Another strategy is the co-expression of
protease inhibitors along with the heterologous protein. For instance, expression of a
cathepsin D inhibitor, S/CD1, was shown to increase protein levels in a proteasomeindependent manner for intrinsic and transgenic proteins expressed in the cytosol (Goulet
et al., 2010). Similarly, expression of the secretory S/CD1 negatively affected the
activities of pepsin-like (A1 family) and trypsin/chemotrypsin-like (S1 family) proteases
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in the apoplast. This strategy was used to increase accumulation levels of C5-1, a murine
antibody, secreted to the apoplast (Goulet et al., 2012).

1.2.4.2

Subcellular targeting

A wide range of proteases are found in plant cells in different organelles including
cytoplasm, vacuole, endoplasmic reticulum (ER), and apoplast, although the number,
quantity and activity of proteases in these organelles are significantly different from one
another (Benchabane et al., 2008). In general, the cytoplasm, lytic vacuole and apoplast
contain a high proteolytic content which results in low accumulation levels of foreign
proteins in these organelles (Goulet et al., 2006). Alternatively, the ER is considered a
mild environment for the production of recombinant proteins due to low abundance of
proteases (Faye et al., 2005). Therefore, to minimize the unintended proteolysis of the
recombinant proteins, the addition of the tetra-peptide KDEL (Lys-Asp-Glu-Leu) or
HDEL (His-Asp-Glu-Leu) is used to retrieve the protein to the ER. Aside from the
availability of fewer proteases in the ER, which provides a protective environment for
recombinant proteins, the abundance of chaperones in the ER also helps with folding
and assembly of heterologous proteins (Desai et al., 2010; Nuttall et al., 2002). Also,
foreign proteins can acquire post-translational modifications in the ER such as disulfide
bond formation and glycosylation (Ma et al., 2003). ER retrieval has been used to
increase accumulation levels of several antibodies, vaccines and cytokines in transgenic
plants (Conley et al., 2009c; Joensuu et al., 2006; Kaldis et al., 2013). Other subcellular
compartments have also been used for targeting proteins including the chloroplast (Van
Molle et al., 2007), protein bodies, and protein storage vacuoles (Stoger et al., 2005)
which will be discussed in details in the next section. It is important to note that although
several successful examples of production of recombinant proteins are mentioned above,
it is often not possible to predict which subcellular compartment will be best suited for
accumulating the recombinant proteins of interest and this is usually empirically
determined by targeting the protein of interest to several organelles (Pereira et al., 2014;
Van Molle et al., 2007).
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1.2.4.3

Targeting to storage organelles

Seeds offer highly specialized organelles for protein storage. These include oil bodies,
protein storage vacuoles and protein bodies. These organelles have been studied for their
potential role in storage of high amounts of recombinant proteins in seeds (Khan et al.,
2012), but also they have been induced in leaves (Conley et al., 2011a; Feeney et al.,
2013).
In seeds, both oil bodies and protein bodies have an ER origin. ER is the biggest
organelle in the plant cell, and is composed of several domains such as cisternal ER,
tubular ER, the nuclear envelope, and plasmodesmata. The tubular domain of the ER
gives rise to oil and protein bodies, as well as protein precursor vesicles, and precursor
accumulation vesicles (Herman, 2008). Also, ER is the most widespread organelle in the
cell that comes into contact, and exchanges content, with several other organelles such as
chloroplasts, Golgi, and plasma membrane (Stefano et al., 2014). Other features of the
ER such as presence of chaperone molecules, the favorable environment for disulfide
bond formation and the absence of significant protease activity makes it an ideal
organelle for protein expression and accumulation (Khan et al., 2012).

1.2.4.3.1

Oil bodies

The major form of seed lipid storage is in oil bodies (OBs). Seeds store triacylglycerols
(TAGs) as a carbon source to use during germination and post-germination growth in
OBs. OBs are spherical organelles ranging between 0.5 to 1 µm and are composed of a
core of TAGs surrounded by a layer of phospholipids and structural proteins known as
oleosins (Hsieh and Huang, 2004).
To target recombinant proteins to OBs, oleosin fusions have been used which accumulate
their fused protein on the membrane of OBs. Recombinant proteins can subsequently be
recovered using a liquid-liquid phase separation by centrifugation and then released by
endoprotease digestion (Boothe et al., 2010). This approach was used for production of
Apolipoprotein A1 (Nykiforuk et al., 2011) and human insulin (Fischer et al., 2012) in
safflower (Carthamus tinctorius) seeds. OB targeting of recombinant proteins is an
appealing strategy because of the relatively low cost of purification; however, this
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technology has several drawbacks: it is limited to seeds and cannot be used in leafy crops,
protein accumulation levels in seed are still not high enough to meet the economical
production requirements, and the efficacy of oleosin-based separation and the postrecovery proteolytic cleavage have been challenged by several studies (Boothe et al.,
2010; Conley et al., 2011a; Kuhnel et al., 2003).

1.2.4.3.2

Protein storage vacuoles

During seed development, storage proteins accumulate in protein storage vacuoles
(PSVs) which will be degraded and used by the embryo during germination. PSVs are
composed of three distinct regions: the matrix, crystalloid and globoid (Jiang et al.,
2001). Proteins can be trafficked to PSVs through different pathways depending on the
tissue (e.g. embryonic or endosperm) or plant species. These pathways include trafficking
through the trans-Golgi network (TGN), precursor-accumulating vesicles (PAC), multivesicular bodies (MVB) or pre-vacuolar compartment (PVC) (Hara-Nishimura et al.,
1998; Hohl et al., 1996). Interestingly, a recent study by Feeney et al. (Feeney et al.,
2013) has shown the possibility of induction of PSVs in Arabidopsis leaves. PSVs
appeared in the vegetative tissue upon overexpression of a key transcriptional regulator of
seed development gene, LEAFY COTYLEDON2 (LEC2).
Seed PSVs have been used for accumulation of several recombinant proteins in a wide
range of plants; Aspergillus niger phytase in pea (Pisum sativum) (Drakakaki et al.,
2006), human coagulation factor IX (hFIX) in soybean (Glycine max) (Cunha et al.,
2011), human acid β-glucosidase (GCase) in tobacco (Nicotiana tabacum) (Reggi et al.,
2005).

1.2.4.3.3

Protein bodies

Protein bodies can be found in different forms in nature. In bacteria they are known as
inclusion bodies (IBs) which are essentially aggregates that form upon high expression
levels of recombinant proteins in their insoluble state and are found in Escherichia coli
(Mayer and Buchner, 2004; Williams et al., 1982). Insoluble aggregates usually form by
over-expression of eukaryotic proteins in prokaryotes. This is because prokaryotic
proteins usually fold post-translationally, whereas eukaryotic proteins require co-
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translational folding. Misfolded proteins initiate a core which grows concentrically by
addition of similar misfolded proteins which will eventually form an equilibrium with the
soluble form of the protein (Baneyx and Mujacic, 2004). Although the content of IBs can
contain up to 95% of a single protein in some cases, they usually include a mixture of
unfolded and folded molecules (García-Fruitós et al., 2005).
More than 100 years ago, William Russell, a Scottish physician, noticed and reported
unusual protein deposits in mammalian epithelial cells which he originally named
fuchsine bodies (Russell, 1890). These structures are now known as Russell bodies (RBs)
and usually form due to accumulation of a certain protein within the ER, for instance a
mutated immunoglobulin that cannot be degraded or secreted due to excessive synthesis.
It is suggested that RB formation is a defense mechanism by the cell against high
amounts of non-transportable molecules that exceed the degradation capacity of the cell
in which the excess molecules are encapsulated by an ER membrane and stored (Mattioli
et al., 2006).
Protein bodies can be found in a similar form in plant seeds as well. Seeds as the major
plant storage tissue contain several classes of storage proteins; albumins (water soluble),
globulins (dilute saline soluble), prolamins (alcohol soluble) and glutelins (dilute acid or
base soluble) (Osborne, 1919). Prolamins are the major class of proteins found in cereals
such as maize, rice and wheat (Shewry et al., 1995), and are generally deposited as dense
accretions in the ER termed protein bodies (PBs) (Larkins and Hurkman, 1978; Pompa
and Vitale, 2006). PBs generally form within the ER lumen but they may bud off upon
reaching a sufficient size and remain in the cytosol or may end up in PSVs by autophagy
(Herman and Larkins, 1999; Levanony et al., 1992).
Because of their ER origin, and their strong role in protein storage, PBs are desirable
organelles to target and store recombinant proteins. Therefore, several attempts have been
made to target recombinant proteins to seed PBs by exploiting motifs that promote
protein aggregation or the ER retrieval signal (KDEL) (Arcalis et al., 2004; Takagi et al.,
2010; Takaiwa et al., 2009; Takaiwa et al., 2007).
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1.2.4.3.4

Induced protein bodies

Several studies have shown the positive impact of protein fusion tags on the
accumulation of recombinant proteins. A few of these fusion tags share another feature,
which is the induction of protein bodies in vivo and include Zera®, elastin-like
polypeptide (ELP) and hydrophobin-I (HFBI) (Conley et al., 2011a; Schmidt, 2013).

1.2.4.3.4.1

Zera fusion tag

Zera® (developed by ERA Biotech, Barcelona, Spain) is the N-terminal proline-rich
domain of γ-zein, a maize prolamin. The Zera sequence is composed of 112 amino acids
which includes the γ-zein signal peptide, the non-proline region containing a Cys-GlyCys motif, the proline-rich repeat region containing (PPVHL)8, and the Pro-X sequence
containing four cysteines (Torrent et al., 2009b). Zera-fused proteins accumulate in the
ER regardless of the presence of an ER retrieval signal peptide (HDEL or KDEL). It was
shown that the two N-terminal cysteine residues in the Cys-Gly-Cys motif are required
for the oligomerization of Zera molecules through intermolecular disulfide bonds (the
first step in PB formation), and that the hexapeptide repeats are critical in PB formation
through facilitating the lateral protein-protein interaction and alignment of Zera
molecules (Llop-Tous et al., 2010). Zera PBs were shown to be surrounded with
membrane-bound ribosomes indicating their rough-ER origin (Llop-Tous et al., 2010).
Zera was shown to induce PBs in several expression systems including mammalian cells
(Chinese hamster ovary (CHO) cells), fungal cells (Trichoderma reesei), insect cells
(Spodoptera frugiperda) and plant leaf cells (Nicotiana tabacum, and Nicotiana
benthamiana) (Torrent et al., 2009a).
Zera-induced PBs can be purified with a density based centrifugation method. Zerafusions have been used for production and purification of several recombinant proteins
including epidermal growth factor, human growth hormone, and Streptomyces derived
xylanases (Llop-Tous et al., 2010; Llop-Tous et al., 2011).
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1.2.4.3.4.2

Elastin-like polypeptide fusion tag

Elastin-like polypeptide (ELP) is composed of VPGXG pentapeptides originally
identified in the mammalian protein elastin. The guest amino acid (X) can be any amino
acid except proline (Urry, 1988). ELPs are thermally responsive molecules which
undergo a reversible phase transition from soluble protein to insoluble aggregates when
heated above their transition temperature (Tt). This property of ELPs can be transferred to
their fused protein partner, and used for the rapid, non-chromatographic purification
method known as inverse transition cycling (ITC) (Meyer and Chilkoti, 1999). The
number of ELP pentapeptides repeats can vary based on the experimental design and
purification preferences. Fewer ELP repeats are more beneficial for protein accumulation
while larger tags are more efficient for purification purposes. An ELP size of 30-40
pentapeptide repeats was found to be a good compromise for both accumulation and
purification (Conley et al., 2009a).
ELP fusions have been used to increase accumulation levels of several recombinant
proteins including spider silk proteins (Patel et al., 2007; Scheller et al., 2004), murine
interleukin-4 (Patel et al., 2007), human interleukin-10 (Kaldis et al., 2013), and antiHIV antibody 2F5 (Floss et al., 2008). Study of the GFP-ELP fusion showed a significant
increase in the amount of GFP (up to 11% of TSP), and also showed the formation of PBs
in N. benthamiana leaves. GFP-ELP-induced PBs are highly mobile organelles which
move along the actin cytoskeleton of the cell. GFP-ELP PBs contain other ER resident
proteins such as BiP and are surrounded with a membrane studded with ribosomes, both
of which may indicate an ER origin for these PBs (Conley et al., 2009b).

1.2.4.3.4.3

Hydrophobin fusion tag

Hydrophobins are a family of small surface-active proteins produced by filamentous
fungi. In fungi, different hydrophobins are expressed at different stages of fungal life
cycle with a wide range of biological roles such as assembly into fungal cell walls,
covering fungal spores or coating fungal surfaces (Linder, 2009). The overall shape of
hydrophobin molecules is globular with an exposed hydrophobic patch which in theory
destabilizes its structure. To challenge destabilization effects of the hydrophobic patch,
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all hydrophobins contain eight cysteine residues in their sequence which form four
intramolecular disulfide bridges responsible for the structural stability of the molecule.
The hydrophobic patch enables hydrophobins to self-assemble at hydrophilichydrophobic interfaces (Wösten and de Vocht, 2000). Hydrophobins can transfer this
property to their fusion partners which can be used for purification using a surfactant
based aqueous two-phase separation system (ATPS) (Linder, 2009).
Hydrophobin-I (HFBI) fusion tag was used to increase the accumulation levels of glucose
oxidase (GOx), an enzyme that could not be expressed in other conventional expression
systems (Bankar et al., 2009). HFBI fusion also increased the accumulation levels of GFP
up to 51% of TSP when transiently expressed in N. benthamiana leaves (Joensuu et al.,
2010), and induced the formation of PBs which cluster together (Conley et al., 2011b;
Joensuu et al., 2010). Similar to Zera- and ELP-induced PBs, HFBI PBs are surrounded
with a distinct ribosome-studded membrane. GFP-HFBI-induced PBs are mobile and
move around the cell similar to GFP-ELP PBs.

1.3 Research goals and objectives
Scalability, rapid regeneration, high production rates, ability to perform co- and posttranslational modifications, and biosafety are some of the numerous advantages of plant
expression systems. Regardless of the fact that plant biotechnology is still a young and
growing technology, it has already been used to produce a wide range of vaccines,
biopharmaceuticals and industrial enzymes. Nevertheless, much room still exists for
significant advances to emerge in the near future. Two of the major challenges hindering
the large scale production of recombinant proteins in plants are low accumulation levels
and lack of efficient purification methods.
PB formation by Zera, ELP and HFBI fusion tags might be one solution to increase low
levels of recombinant protein accumulation in plants and to facilitate protein purification
at the same time. However, not much is known about PBs. The subcellular origin of PBs
as well as the mechanism by which the fusion tags induce the formation of PBs and
consequently increase the accumulation levels of recombinant proteins are not well
understood and form the basis of this thesis. The specific objectives of my project were:
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1- To study the biogenesis of PBs. The effects of recombinant protein
concentration (accumulation levels), subcellular targeting of the recombinant
protein, and the role of fusion tags were examined in the process of PB
formation.
2- To study the role of PB size in increasing accumulation levels of recombinant
proteins. The size of PBs induced by ELP and HFBI fusion tags were measured
and correlated with their respective accumulation levels.
3- To study the means of sequestration of recombinant proteins into PBs. The
role of fusion-tag-induced PBs in increasing the accumulation levels of unfused
recombinant proteins, erythropoietin and interleukin-10, were assessed.
4- To address the question whether PBs are terminally stored cytoplasmic
organelles or if they remain as part of the ER. A GFP photoconversion method
was developed which enabled the tracking of photoconverted molecule
movement between PBs and through the ER.
5- To confirm the ER origin of PBs induced by Zera, ELP and HFBI fusion tags.
The ER origin of PBs was examined by co-expression with an ERtransmembrane protein.
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2.1 Introduction
During the past two decades, plants have been extensively studied as efficient green
bioreactors for production of recombinant proteins (Egelkrout et al., 2012). In 2012, the
first plant-produced pharmaceutical protein was approved by the US Food and Drug
Administration (Maxmen, 2012). Several host plants and production systems including
seed- and leaf-based systems have been used for producing recombinant proteins, but
Nicotiana benthamiana has emerged as the best platform for scalable rapid recombinant
protein production in transient expression systems (Tremblay et al., 2010).
Seeds are naturally suited to produce and store high levels of proteins. High protein
content, low protease activity and low water content make seeds very attractive for
producing and accumulating target proteins (Benchabane et al., 2008). Seeds have
developed specialized protein storage organelles such as protein bodies (PBs), protein
storage vacuoles (PSVs) and oil bodies (Khan et al., 2012). Over the years, several plantmade pharmaceuticals and industrial recombinant proteins have been produced in plant
seeds (Lau and Sun, 2009). However, seed-based expression systems face issues related
to biocontainment due to the possibility of gene leakage into the environment through
distribution of seed or pollen. As well, relatively long periods of time are required to
generate transgenic plant lines and screen them for high expressing lines (Ma and Wang,
2012).
Unlike seed-based systems, leaves can be harvested before flowering therefore
minimizing the risk of gene leakage to the environment. In addition, leaves produce high
biomass yield along with high soluble protein content on a hectare (or surface) basis.
Among leaf-based expression systems, Agrobacterium-mediated transient expression in
leaves of Nicotiana benthamiana, a relative of tobacco, has become widely used as a
rapid and high-yielding platform for production of high levels recombinant proteins. This
is due to the flexibility of this system as it allows for the expression of multiple genes
simultaneously, is amenable to transferring large genes (greater than 2 kb) and allows for
rapid (within a week) production of recombinant proteins (Pogue et al., 2010).
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Although leaf-based expression systems have advantages for biocontainment and speed,
the production yield of recombinant proteins is often low due to proteolytic degradation
of foreign proteins (Benchabane et al., 2008; Fischer et al., 2004). Several fusion tags
such as Zera®, elastin-like polypeptides (ELPs) and hydrophobins (HFBs) have been used
to improve accumulation levels of recombinant fusion partners in leaves (Conley et al.,
2011). These three fusion tags were hypothesized to improve accumulation of
recombinant proteins by sequestering them in novel organelles reminiscent of seed PBs
that protect target proteins from proteolytic degradation. The use of these fusion tags
were shown not only to induce PBs but also to facilitate the process of recombinant
protein purification (Conley et al., 2011; Khan et al., 2012; Torrent et al., 2009b).
Zera® is a proline-rich region at the N-terminal region of a maize storage protein known
as γ-zein (Llop-Tous et al., 2010). Proteins fused to Zera® were found in the form of PBs
in a wide range of host cells including mammalian, insect, fungi and plants (Torrent et
al., 2009b). Zera-fused proteins accumulate in the endoplasmic reticulum (ER)
independent of the conventional ER retrieval signal (HDEL/KDEL) and it is thought that
the interaction of Zera® with the ER membrane induces the budding of PBs from the ER.
The Zera-induced PBs can be purified by gradient density-centrifugation (Torrent et al.,
2009a).
ELPs are synthetic biopolymers of repeating pentapeptides, Val-Pro-Gly-Xaa-Gly,
similar to repetitive pentapeptides of the mammalian protein elastin, in which the guest
amino acid (Xaa) can be any amino acid except proline. ELP tags can be used for the
rapid, non-chromatographic purification method called inverse transition cycling (ITC)
(Urry and Parker, 2002). This method has been used to increase accumulation levels and
to assist with the purification of several recombinant proteins (Floss et al., 2010). An ERretrieved GFP-ELP fusion was shown to induce the formation of PBs as well as boost
accumulation levels of the fused recombinant protein both in transient and transgenic
expression (Conley et al., 2009b; Gutierrez et al., 2013).
Hydrophobins are surface-active proteins originally found in fungi (Wessels, 1997).
Hydrophobins share eight conserved cysteine residues responsible for the formation of
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four intramolecular disulfide bridges which maintain the structural stability of the
molecule. The rigid core enables hydrophobins to display a group of hydrophobic amino
acids on their surface forming a “hydrophobic patch” responsible for their amphiphilic
nature (Hakanpää et al., 2004). Therefore, hydrophobins can self-assemble at
hydrophilic-hydrophobic interfaces, a property that can be exploited for purification
using a surfactant based aqueous two-phase separation system (ATPS) (Linder et al.,
2001). Hydrophobin-I (HFBI) fusion has been used to increase the accumulation levels of
several recombinant proteins, including GFP, and to induce PB formation in vivo similar
to ELP by transient and transgenic expression (Gutierrez et al., 2013; Joensuu et al.,
2010; Lahtinen et al., 2008).
In this study I compared ELP and HFBI fusion tags in the process of PB formation. I
showed that PB formation is not exclusively promoted by the fusion tags and that protein
accumulation level is a critical element involved in this process. My results indicate that
PB formation is not a selective mechanism and proteins targeted to the secretory pathway
can be passively sequestered into PBs. I have used this property of PBs as a novel
approach to increase the accumulation levels of erythropoietin and human interleukin-10.

2.2 Results
2.2.1

Elastin-like polypeptides induce larger protein bodies than
hydrophobin-I

To compare the effects of ELP and HFBI fusion tags on PB formation and accumulation
levels of their fused proteins, constructs (Conley et al., 2009b; Joensuu et al., 2010)
targeting GFP to the endomembrane system (Figure 2.1) were co-agroinfiltrated into
N. benthamiana with a construct containing the suppressor of gene silencing, p19, from
Cymbidium ringspot virus (CymRSV) (Silhavy et al., 2002). Previous independent
reports had shown that GFP fusion with ELP or HFBI increased the accumulation levels
of the GFP and gave rise to clusters of PBs with variable distribution patterns (Conley et
al., 2009b; Joensuu et al., 2010). To compare PBs induced by ELP or HFBI and
consequent GFP accumulation levels, the sizes of PBs induced by GFP-ELP and GFP- HFBI
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Figure 2. 1 Schematic representation of constructs used for Agrobacterium-mediated
transient expression in N. benthamiana leaves.
Pr1b, secretory signal peptide from the tobacco pathogenesis-related protein 1; EGFP,
enhanced green fluorescent protein; GOI, gene of interest; L, linker (GGGS)3; TEV,
tobacco etch virus protease recognition site; c-myc, detection tag; KDEL, endoplasmic
reticulum retrieval tetra peptide; ELP, elastin like polypeptide; HFBI, hydrophobin-I;
EPO, human erythropoietin; HIS, (His)6 purification tag; hIL-10, human interleukin-10;
Strep ll, purification tag. In GOI, GOIs include EGFP, xyn10A, or xyn11A. In GOI-ELP,
GOIs include EGFP or RFP. In GOI-HFBI, GOIs include EGFP, RFP, or xyn11A.
Schematic not drawn to scale.
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were measured and the amount of GFP produced in every treatment was quantified 3, 4
and 5 days post infiltration (dpi) (Figure 2.2). To obtain accurate measurements of all
PBs within a cell, protoplasts were isolated from the infiltrated leaf tissue and used for
imaging by confocal microscopy. Z-stack assemblies of 1.5 to 2 µm slices spanning
entire protoplasts and covering approximately 70 to 80 µm were used for threedimensional visualization. With this technique, PBs within the cell were visualized and
their detailed information was analyzed using the Imaris software (Figure 2.2a-b)
(Supplementary Movie 2.1).
Day to day comparison of ELP- and HFBI-induced PBs suggests that ELP-induced PBs
were significantly larger in size than HFBI-induced PBs (Figure 2.2c). At 3 and 4 dpi,
75% of the ELP-induced PBs were larger than 1.7 µm in diameter with the median of
approximately 2.4 µm, while 75% of the HFBI-induced PBs were smaller than 1.7 µm in
diameter with the median of approximately 1.2 µm. At 5 dpi, the PBs were bigger in both
the ELP and HFBI fusions, with 75% of the ELP-induced PBs larger than 2 µm in
diameter with the median of 2.7 µm while 50% of the HFBI-induced PBs were also
within this range with the median located at 2 µm. The maximum size of GFP-ELPinduced PBs increased from 5.5 µm at 3 dpi to 9 µm at 5 dpi while the maximum size of
HFBI-induced PBs increased from 4 µm at 3 dpi to 7.7 µm at 5 dpi.
I found that PB size and protein accumulation levels increase simultaneously, as the size
increase of ELP- or HFBI-induced PBs was accompanied with an increase in GFP
accumulation from 21 and 24% of TSP at 3 dpi for GFP-ELP and GFP-HFBI respectively
to 40% of TSP at 5 dpi for both proteins (Figure 2.2d).

2.2.2

Protein

body

formation

is

a

concentration-dependent

mechanism
Previous studies have shown that by addition of fusion tags, the accumulation levels
of recombinant proteins can increase (Conley et al., 2009a; Joensuu et al., 2010;
Kaldis et al., 2013; Torrent et al., 2009a). Conley et al. (2009b) have also shown that
by co-agroinfiltrating GFP-ELP and p19, a suppressor of post-transcriptional gene
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Figure 2. 2 Protein body size and GFP accumulation in protoplasts expressing GFP-ELP
and GFP-HFBI increase simultaneously.
(a) 2D representation of the Z-stacks acquired from a protoplast expressing GFP-ELP at
4 dpi. (b) 3D-rendered Z-stack image of the protoplast shown in (a). (c) Size distribution
pattern of GFP-ELP- and GFP-HFBI-induced PBs based on their respective diameters
(µm) from 3 to 5 days post infiltration (dpi). The box represents the middle 50% of the
protein body size distribution, and upper and lower “whiskers” represent the entire spread
of the data acquired from 10 protoplasts per day per treatment; dotted lines indicate
pairwise significant differences at * p < 0.0001 using Kruskal-Wallis one-way analysis of
variance test. (d) GFP accumulation levels as a percentage of total soluble protein (TSP).
Four biological replicates (each replicate containing four leaf discs of the infiltrated tissue
from a different plant) were used for fluorometry. Columns not denoted with the same
letter are significantly different from each other (p < 0.05) using one-way ANOVA. Error
bars represent the standard error of the mean from biological replicates.

Diameter (µm)
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silencing (Silhavy et al., 2002), recombinant protein levels increase and PB formation is
induced in a higher percentage of cells. Surprisingly, using the same experimental setup
with unfused GFP, PBs were found in over 40% of the examined cells, suggesting a
potential role for increased protein accumulation in the process of PB formation (Conley
et al., 2009b).
To investigate the effect of recombinant protein accumulation on PB formation, I
conducted an experiment with a gradient of GFP levels. The GFP gradient was achieved
by co-infiltrating a dilution series matrix of Agrobacterium containing the respective GFP
constructs at an OD at A600 of 0.015 to 0.05 and the p19 suppressor of posttranscriptional gene silencing at OD A600 of 0.01 to 0.05. As expected, GFP accumulation
levels increased with increasing Agrobacterium optical density (data not shown).
To compare the effects of fusion tags on PB formation at similar concentrations, I divided
the treatments based on their respective accumulation levels into low (~ 0.2% of TSP),
and high (> 6.5% of TSP) categories (Figure 2.3a) and looked for the effect of protein
concentration on PB formation in each category (Figure 2.3b-g). At low accumulation
levels, ER-targeted GFP highlighted the typical ER network pattern with minuscule PBs
appearing along the ER network (Figure 2.3b). At a similar accumulation level of around
0.2% of TSP, both GFP-ELP and GFP-HFBI produced PBs. GFP-ELP-induced PBs were
larger in size (in some cases reaching 5 µm) compared to GFP-HFBI-induced PBs,
although the number of GFP-HFBI-induced PBs was larger (Figure 2.3c-d).
On the other hand, PBs were present in all treatments when accumulation levels were
high (> 6.5% of TSP), irrespective of the presence or absence of the fusion tags (Figure 2.3 e-g).
As shown in figure 2.3e, ER-targeted GFP induced PBs with sizes ranging from very
small (~ 0.5 µm) to very large (~ 6 µm). At similar accumulation levels, GFP-ELP and
GFP-HFBI induced higher numbers of homogenously sized PBs that were clustered
together (Figure 2.3f-g). GFP-ELP generally induced PBs that were larger than GFPHFBI. The appearance of very small PBs at 0.2% of TSP in the unfused GFP treatment,
and their increase in number and size at higher accumulation levels indicates that levels
of GFP, and possibly any other protein accumulating at high levels, may play a major
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Figure 2. 3 High recombinant protein concentration leads to protein body formation.
(a) Leaf tissue samples were divided into low and high expressing groups and monitored
for PB formation. Error bars represent the standard deviation of the mean from technical
replicates quantified by dot blots. (b-d) PB formation in leaf tissues with low
accumulation levels (~ 0.2% of TSP). Leaf tissue was infiltrated with GFP, GFP-ELP and
GFP-HFBI in (b), (c) and (d), respectively. (e-g) PB formation in leaves with high
accumulation levels (> 6.5% of TSP). Leaf tissue was infiltrated with GFP, GFP-ELP and
GFP-HFBI in (e), (f) and (g), respectively. Bar, 10 µm.
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role in PB biogenesis. The different patterns of PB appearance, i.e. their clustering and
size uniformity may be due to the physico-chemical properties of the ELP and HFBI tags.

2.2.3

Secretory or ER-targeted proteins are sequestered passively
into protein bodies

A proteomics study of the composition of Zera-induced PBs has shown the presence of a
broad range of proteins other than Zera, including secretory pathway proteins, in PBs
(Joseph et al., 2012). Conley et al. (2009b) also showed that the ER-resident chaperone
BiP is found in GFP-ELP-induced protein bodies. Therefore, I hypothesize that during
the formation of PBs, secretory or ER resident proteins can be sequestered passively into
the core of the PBs. To understand if this is the case, I co-expressed secretory GFP or
ER-targeted GFP along with RFP-HFBI and RFP-ELP. All of the treatments were
performed in the presence of p19 to ensure high accumulation levels.
Secretory GFP highlighted the apoplastic space between the cells without formation of
PBs (Figure 2.4a), while ER-targeted GFP induced the formation of very small PBs along
the ER network (Figure 2.4b). As expected, both RFP-HFBI and RFP-ELP gave rise to
clusters of homogeneous PBs with RFP-ELP PBs being larger in size (Figure 2.4c-d).
Co-expression of secretory GFP and RFP-HFBI (Figure 2.4e-g) or RFP-ELP
(Figure 2.4h-j) resulted in the sequestration of secretory GFP into HFBI- or ELP-induced
PBs, shown by co-localization of both green and red fluorescent proteins into the same
PBs. Co-expression of ER-targeted GFP with RFP-HFBI and RFP-ELP also resulted in
the sequestration of GFP into PBs induced by HFBI and ELP (Figure 2.4k-m, and 2.4np). In all of the co-expression treatments, the typical HFBI- or ELP-induced clustered
patterns of PBs were observed (Figure 2.4e-p). My results indicate that proteins targeted
to the secretory pathway, or retrieved to the ER (Figure 2.1) can be sequestered into
HFBI- or ELP-induced PBs.
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Figure 2. 4 Secretory and ER-targeted GFP are sequestered into RFP-HFBI and RFPELP induced protein bodies.
(a) Secretory GFP localizes to the apoplast. (b) ER-targeted GFP induces the formation of
small PBs along the ER. (c) ER-targeted RFP-HFBI induces the formation of clusters of
small PBs. (d) ER-targeted RFP-ELP induces the formation of large PB clusters. (e-g)
Co-expression of Sec-GFP and RFP-HFBI results in sequestration of secretory GFP into
RFP-HFBI-induced PBs. (h-j) Co-expression of Sec-GFP and RFP-ELP results in
sequestration of secretory GFP into RFP-ELP-induced PBs. (k-m) Co-expression of GFP
and RFP-HFBI results in co-localization of both proteins into the same PBs. (n-p) Coexpression of GFP and RFP-ELP results in co-localization of both proteins into the same
PBs. All images were acquired in sequential mode. Bar, 10 µm.
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2.2.4

Fungal xylanases induce the formation of protein bodies

To determine if PB formation is limited to GFP or occurs upon overexpression of other
proteins, I examined the possibility of PB formation with two other recombinant proteins
accumulating at or higher than 0.2% of TSP. Two fungal xylanases from Aspergillus
niger known as xyn11A (Nordberg et al., 2014) with and without the HFBI tag, and
xyn10A (Nordberg et al., 2014) were selected and targeted to the ER with the ERretrieval tetrapeptide KDEL (Figure 2.1). Accumulation levels of the three recombinant
proteins were quantified by quantitative Western blot analysis at 4 and 6 dpi (Figure 2.5ab). Xyn11A-HFBI accumulated to 2.1% of TSP at 6 dpi, almost 10-fold higher than the
unfused enzyme. Based on my results with GFP, PB formation was expected in all three
groups. The subcellular localization of xyn11A, xyn11A-HFBI and xyn10A, was
determined by the whole-mount immunolocalization of the infiltrated leaf tissue using
anti c-myc monoclonal mouse antibody as the primary antibody and donkey anti-mouse
IgG antibody fused to Alexa Fluor® 488 dye as the secondary antibody, followed by
confocal microscopy analysis. As shown in figure 2.5c and 2.5e, xyn11A and xyn10A
induced the formation of dispersed PBs irregular in size, whereas higher accumulating
xyn11A-HFBI induced numerous clustered PBs homogeneous in size (Figure 2.5d). This
property of xyn11A-HFBI resembles the typical pattern of HFBI-induced PBs previously
observed with GFP-HFBI. According to these results, I conclude that PB formation is not
limited to GFP or its fusion partners and can be seen with other recombinant proteins as
well.
Since xyn11A and xyn11A-HFBI induce the formation of PBs, and since I observed that
secretory GFP is sequestered in RFP-HFBI-induced PBs, I asked if secretory GFP would
be also sequestered in xyn11A-induced PBs. If so, simple co-localization of secretory
GFP would provide a tool for visualizing PBs induced by non-fluorescent proteins
without having to conduct immunolocalization, a lengthy and arduous process. I found
that co-expression of xyn11A and xyn11A-HFBI with sec-GFP indeed allowed me to
visualize the xyn11A-induced PBs. As shown in figure 2.6a, secretory GFP was localized
to the apoplastic space of N. benthamiana leaf epidermal cells. Co-expression of secretory
GFP and xyn11A resulted in sequestration of secretory GFP into xyn11A-induced
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Figure 2. 5 Fungal xylanases accumulate in PBs.
xyn11A, xyn11A-HFBI and xyn10A xylanase proteins were co-expressed with p19 in
N. benthamiana leaves. Leaf discs from 4 individual plants at 4 and 6 dpi (a-b) Equal
amounts of TSP (3 µg) was loaded per lane. TSP from p19-infiltrated N. benthamiana
tissue was used as negative control. Known amounts of a c-myc tagged protein were used
as reference (12.5-100 ng). (a) Western blot analysis. (b) Quantification of (a). by
densitometry. (c-e) PBs were visualized by confocal microscopy after whole-mount
immunolocalization. Bar, 10 µm.
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PBs (Figure 2.6b). These large PBs were found in all of the cells producing PBs in the
infiltrated tissue (Table 2.1). Similarly, co-expression of the secretory GFP and xyn11AHFBI resulted in sequestration of secretory GFP into xyn11A-HFBI-induced PBs. As
expected, these PBs were all small and homogenous in size and formed clusters (Figure
2.6c). This pattern was consistently observed in all of the cells forming PBs (Table 2.1).
Also, since I observed the sequestration of ER-targeted GFP into RFP-HFBI-induced
PBs, I examined the possibility of sequestration of ER-targeted GFP into xyn11Ainduced PBs. Even though ER-targeted GFP induced the formation of minuscule PBs
along the ER network (Figure 2.6d), its co-expression with xyn11A resulted in the
appearance of large PBs (Figure 2.6E). Co-expression of GFP-ER and xyn11A-HFBI,
gave rise to clusters of homogenously-sized small PBs along with a number of large PBs
(Figure 2.6f), (Table 2.1). My results suggest that in the process of PB formation,
proteins present in the ER, such as proteins on their way to secretion (secretory GFP) or
ER-retrieved proteins (GFP-KDEL) are sequestered into PBs.

2.2.5

PB induction can be used as a tool to increase accumulation
levels of valuable proteins

My results indicate that proteins accumulating at levels higher than 0.2% of TSP are
capable of PB formation in vivo, and that proteins targeted to the secretory pathway or
retrieved to the ER using a KDEL retrieval signal can be sequestered into PBs. Based on
these observations, and because I believe that PBs may protect recombinant proteins from
turnover, I hypothesized that I can use PB formation as a strategy to help increase the
accumulation levels of other recombinant proteins that do not accumulate at high levels. I
first tested this hypothesis by co-expressing erythropoietin (EPO) with other proteins
already shown to accumulate at high levels and induce PBs such as GFP, GFP-ELP, and
GFP-HFBI (Lee et al., 2012). EPO is a glycoprotein best known for its regulatory roles in
production of red blood cells and its applications in the treatment of anemia caused by
renal failure, chemotherapy and AIDS (Lee et al., 2012).
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Figure 2. 6 Secretory and ER-retrieved GFP localize to protein bodies induced by fungal
xylanases.
(a) Secretory GFP highlights the apoplast of N. benthamiana epidermal cells. (b-c)
Co-expression of secretory GFP with xyn11A (b) and xyn11A-HFBI (c) results in
localization of secretory GFP to PBs. (d) ER targeted GFP highlights the ER network and
induces the formation of very small PBs along the ER. (e-f) Co-expression of GFP with
xyn11A (e) and xyn11A-HFBI (f) results in localization of GFP to PB clusters. Bar, 10
µm.
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Table 2. 1 Occurrence and size distribution of PBs in cells transiently transformed with
different constructs.
Protein body
Treatments a

Protein body size

Presence
(%)
0

Absence b
(%)
100

Small c
(%)
0

Large d
(%)
0

SecGFP / xyn11A

61

39

0

100

SecGFP / xyn11A-HFBI

48

52

100

0

GFP

71

29

90

10

GFP / xyn11A

90

10

43

57

GFP / xyn11A-HFBI

87

13

51

49

SecGFP

a

To avoid any bias, presence or absence of PBs in 100 cells in four biological replicates
(25 cells per replicate) were evaluated per treatment with confocal microscopy at 4 dpi.
b

c

No PBs was observed in these cells.

Maximum PB diameter was <1.0 µm.

d

Maximum PB diameter was >1.0 µm.
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EPO transiently co-expressed with p19 in N. benthamiana leaves accumulated at 0.045%
(± 0.012%) of TSP, almost a five-fold increase compared to the very low transient
expression of the same EPO construct without p19 using binary vectors (Figure 7a)
(Conley et al., 2009a; 2009c). Therefore, p19 was used in all further experiments to
obtain high accumulation levels of the recombinant proteins. Using the same construct as
Conley et al. (Conley et al., 2009c), co-expression of EPO in this work with GFP-ELP
and GFP-HFBI, EPO accumulation levels were enhanced significantly by two-fold up to
0.086% (± 0.017%) of TSP with GFP-ELP, and more than three-fold up to 0.141% (±
0.012%) of TSP with GFP-HFBI (Figure 7a). Co-expression of EPO with GFP showed
an increase in the mean EPO accumulation but not a significant difference from EPO
expressed alone (Figure 2.7a).
To further validate the idea that accumulation of valuable unfused proteins can be
increased by co-expression with a PB-inducing fusion, the human cytokine interleukin-10
(hIL-10) was co-expressed with GFP-HFBI. Human IL-10 is an anti-inflammatory
cytokine with multiple roles in the regulation of the immune responses (Denes et al.,
2010). Several previous attempts to express unfused hIL-10 in plants resulted in low
accumulation levels including expression in transgenic tobacco (accumulating at
0.0055% of TSP) (Menassa et al., 2001), BY-2 cell suspension cultures (accumulating at
0.046% of TSP) (Kaldis et al., 2013), and transient expression in N. benthamiana
(accumulating at approximately 0.05% of TSP) (Conley et al., 2009a). Transient coexpression of hIL-10 with p19 increased hIL-10 accumulation levels to 0.258% (± 0.056)
of TSP. Upon co-expression of IL-10 with GFP-HFBI and p19, accumulation levels of
IL-10 were significantly increased almost three-fold, up to 0.692% (± 0.279) of TSP
(Figure 2.7b). This is approximately 125-fold higher than transgenic tobacco plants
(Menassa et al., 2001), and 15-fold higher than BY-2 cell culture (Kaldis et al., 2013) or
N. benthamiana transient expression in the absence of p19 (Conley et al., 2009a).
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Figure 2. 7 Co-expression of EPO and IL-10 with PB-inducing proteins increases EPO
and IL-10 accumulation.
(a) Co-expression of erythropoietin (EPO) with GFP, GFP-ELP and GFP-HFBI. Enzymelinked immunosorbent assay (ELISA) of recombinant EPO was used to quantify EPO
accumulation levels in agroinfiltrated N. benthamiana leaves. (b) Co-expression of
interleukin-10 (IL-10) with GFP-HFBI. IL-10 accumulation levels were determined by
ELISA. Each column represents the mean value of eight biological replicates. Columns
denoted with different letters are significantly different (p < 0.002) using the student
t-test. The error bars represent the standard error of the mean.
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2.3 Discussion
2.3.1

Protein body size and recombinant protein accumulation
increase simultaneously

Characterization of PBs induced by GFP-ELP and GFP-HFBI revealed a clear size
difference in PBs induced by the fusion tags in N. benthamiana leaf protoplasts. I have
shown that ELP-induced PBs are larger than HFBI-induced PBs. Comparison of the data
with the sizes of Zera-induced PBs (Llop-Tous et al., 2010) suggests that both ELP and
HFBI induce PBs larger than Zera. In this study, I used a novel technique by combining
confocal imaging and 3D analysis to accurately measure the sizes of all of the PBs inside
the protoplasts. The results presented here confirm that the size of ELP- and HFBIinduced PBs increase over time as well as their associated amount of fused recombinant
protein. Previous studies by Llop-Tous et al. (2010) indicated that the size of Zera-ECFPinduced PBs increase over time from 2 to 10 dpi. This property of Zera-induced PBs was
attributed to the continuous biosynthesis of Zera-ECFP polypeptides by the ER active
ribosomes (Llop-Tous et al., 2010). In 2012, Joseph et al., showed that Zera-DsRed PBs
were surrounded with a typical ER membrane decorated with ribosomes. Similarly, GFPELP- and GFP-HFBI-induced PBs were shown to be surrounded with membranes
studded with ribosomes (Conley et al., 2009b; Joensuu et al., 2010). My results, in
accordance with previous observations, suggest a possible role for ribosomes attached to
membranes surrounding PBs in the increase in sizes of GFP-ELP- and GFP-HFBIinduced PBs from 3 to 5 dpi and the simultaneous increase in the amount of GFP during
this time period. Meanwhile, in a series of fluorescent recovery after photobleaching
(FRAP) experiments, Conley et al. (2009b) have shown recovery of GFP-ELP into
photobleached PBs (within 5 minutes), which suggests the possibility of trafficking of
GFP-ELP from surrounding PBs into the photobleached PB. Although protein trafficking
between PBs or between the ER and the PBs needs further confirmation, it can still be
considered a potential factor responsible for increasing the sizes of GFP-ELP- and GFPHFBI-induced PBs.
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2.3.2

Role of protein accumulation level in protein body formation

The occurrence of PBs in unfused ER-retrieved GFP and the increase in PB size at higher
GFP accumulation levels suggests a direct role of protein accumulation in PB formation.
This observation is consistent with a previous study in which a threshold level of protein
accumulation was observed at 0.2% of TSP in transgenic tobacco plants expressing GFP,
GFP-ELP and GFP-HFBI (Gutierrez et al., 2013). Below 0.2% of TSP, no PBs were
observed, while above 0.2% of TSP PBs were observed in almost all plants, regardless of
the fusion tag. I confirmed the formation of PBs with fungal xylanases xyn11A and
xyn10A, both of which reached accumulations slightly above 0.2% of TSP. Addition of
the HFBI fusion tag to xyn11A not only increased accumulation levels by 10-fold, but
also produced more PBs with the typical small and clustered HFBI-associated PB pattern.
This pattern was previously observed with GFP-HFBI-induced PBs in independent
studies (Gutierrez et al., 2013; Joensuu et al., 2010). Although I have shown that PBs
form regardless of the availability of fusion tags above the threshold level, the
distribution pattern and sizes of PBs were affected by the fusion tags, with obvious
clustering and with larger PBs produced by ELP as compared to HFBI.

2.3.3

Protein body formation, a new tool in increasing recombinant
protein accumulation

A proteomics study of Zera-DsRed-induced PBs has previously shown that aside from
Zera-DsRed, which composed the majority of PB content, other ER resident and
secretory proteins were found in PBs (Joseph et al., 2012). In an independent study, the
co-expression of ER-resident molecular chaperone binding protein (BiP) fused with CFP
(BiP-CFP-KDEL)

and

ER-targeted

YFP-ELP

(YFP-ELP-KDEL)

showed

the

sequestration of the ER chaperone BiP into the YFP-ELP-induced PBs (Conley et al.,
2009b). Furthermore, co-immunoprecipitation analysis of these two proteins suggested
that BiP does not specifically interact with the ELP (Conley et al., 2009b). This might
have been due to the passive sequestration of BiP into the YFP-ELP-induced PBs. My
results also confirmed the passive sequestration of ER-retrieved and secretory proteins
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into PBs. This was shown separately by sequestration of secretory GFP and ER-retrieved
GFP into RFP-HFBI- , RFP-ELP-, xyn11A-HFBI- and xyn11A-induced PBs.
Based on the observations of passive sequestration of ER resident proteins into PBs, I
designed a series of experiments to study the potential of PB induction as a new approach
to increase recombinant protein accumulation in plants. EPO and hIL-10 were chosen
since they are both highly valuable pharmaceutical proteins that accumulate at low levels
when expressed in plants. Although recent reports have shown accumulation levels of
EPO fusions to high levels; EPOFc to 0.18% of TSP and EPO-ELD to approximately 2%
of TSP by using viral based magnICON® vectors (Castilho et al., 2013; Jez et al., 2013),
the highest accumulation level achieved in plants using binary vectors approached 0.01%
of TSP in transient expression and up to 0.05% of TSP in transgenic tobacco (Conley et
al., 2009c). Here I have shown that by co-expressing EPO with a PB-inducing construct
and p19, I could increase EPO accumulation levels up to 0.14 % of TSP, 14-fold higher
than the previously reported transient expression levels using binary vectors (Conley et
al., 2009c).
Human IL-10 was previously expressed in several plant systems including transgenic
tobacco, transgenic BY-2 cell lines and transiently in N. benthamiana, and in all cases
accumulated below 0.05% of TSP (Conley et al., 2009a; Kaldis et al., 2013; Menassa et
al., 2001). By co-expressing hIL-10 and GFP-HFBI, hIL-10 accumulated up to 0.69%
TSP on average, which is approximately a 14-fold increase from the highest previously
reported hIL-10 accumulation level. This increase in accumulation levels of ER-targeted
EPO or hIL-10 might be due to non-selective sequestration of ER-targeted proteins into
PBs. I hypothesize that by co-expressing low-accumulating valuable proteins such as
EPO and hIL-10 with high accumulating PB-inducing proteins, both recombinant
proteins are sequestered in PBs. It has already been proposed that PBs protect
recombinant proteins from physiological turnover within the cell (Conley et al., 2011;
Khan et al., 2012; Müntz and Shutov, 2002), which might consequently explain the
increased accumulation levels of EPO and hIL-10 in this work. It is worth noting that
hIL-10-ELP fusion expressed in BY-2 cell lines were shown to accumulate to 3% of TSP;
however the activity of the fused hIL-10 was significantly reduced when fused to ELP
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(Kaldis et al., 2013). With my proposed co-expression technique, the need for addition of
fusion tags that might affect the proper folding and activity of their fused partner is
eliminated.

2.4 Conclusions
In conclusion, the main objectives of this study were to understand the role of fusion tags
and recombinant protein accumulation levels in the process of PB formation, and to
investigate the potential utility of PBs as a tool to facilitate recombinant protein
production in leaves of N. benthamiana. I have shown that the ELP fusion tag induces
PBs larger in size compared to HFBI and that the PB size correlates with protein
accumulation levels. I have also shown that presence of ELP or HFBI fusion tags is not
necessary for PB formation, which occurs with several ER-targeted genes, but that ELP
and HFBI affect the distribution patterns and size of PBs. I have also shown that PB
formation is not limited to the conventional fluorescent proteins (e.g. GFP or RFP) as
fungal xylanases also induce PBs. In addition, my results indicate that in the process of
PB formation, secretory and ER resident proteins can passively integrate into the lumen
of PBs. This property of PBs was used as a tool to increase accumulation levels of EPO
and hIL-10 by co-expression with PB-inducing proteins.

2.5 Experimental procedures
2.5.1

Construct design and cloning

Secretory GFP, GFP, GFP-ELP, GFP-HFBI, and EPO plant expression vectors were
previously published (Conley et al., 2009b; 2009c; Joensuu et al., 2010). The coding
sequence

of

RFP

was

PCR

amplified

using

primers

RS1

(5’GGGGACAAGTTTGTACAAAAAAGCAGGCTTGATGGCCTCCTCCGAGGACG
T3’) and RS2 (5’GGGGACCACTTTGTACAAGAAAGCTGGGTCGGCGCCGGTGGAGTGGC3’). The PCR construct was then inserted into the Gateway® donor vector
pDONR/Zeo™ (Invitrogen, Carlsbad, USA). The integrity of the PCR construct was
confirmed with sequencing analysis. Using Gateway technology, RFP was recombined
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into the pCamGate-ER, pCamGate-HFBI-ER and pCamGate-ELP-ER (Figure 2.1)
expression vectors (Conley et al., in preparation) under the control of a double-enhanced
cauliflower mosaic virus (CaMV) 35S promoter (Kay et al., 1987; Wu et al., 2001), a
tCUP translational enhancer (Malik et al., 2002) and a nopaline synthase (nos) terminator
(Bevan et al., 1983).

The final expression constructs were then transformed into

Agrobacterium tumefaciens strain EHA105. The xyn11A and xyn11A-HFBI plant
expression vectors were obtained from Ruoyu Yan (Yan, 2011).

2.5.2

Nicotiana benthamiana growth and maintenance

Nicotiana benthamiana plants were grown for 7 weeks and used for transient expression.
Plants were grown in a growth chamber at 22˚C with a 16 hour photoperiod at a light
intensity of 110 µmol m-2 s-1. Plants were always watered with the water soluble fertilizer
(N : P : K = 20 : 8 : 20) at 0.25 g/L (Plant Products, Brampton, ON, Canada).

2.5.3

Transient expression in Nicotiana benthamiana plants

Agrobacterium tumefaciens cultures were grown to an optical density at 600 nm (OD600)
of 0.5-0.8, and collected by centrifugation at 1000 g for 30 minutes. The pellets were then
resuspended in Agro-infiltration solution (3.2 g/L Gamborg’s B5 medium and vitamins,
20 g/L sucrose, 10 mM MES pH 5.6, 200 μM 4′-Hydroxy-3′,5′-dimethoxyacetophenone)
to a final OD600 of 0.30, followed by incubation at room temperature (21˚C) with gentle
agitation for 1 hour. The suspension was then used for infiltration of the abaxial leaf
epidermis through the stomata of N. benthamiana plants with a 1 ml syringe (Kapila et
al., 1997).

2.5.4

Tissue sampling and protein extraction

N. benthamiana leaf samples were collected at 4-6 dpi depending on the experiment.
Four leaf discs were collected from at least three biological replicates per sample. Total
soluble protein was extracted and quantified as previously described (Conley et al.,
2009a).
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2.5.5

Protoplast preparation

Protoplasts were prepared as described by Sheen (2002). Briefly, 1 g of infiltrated leaf
tissue was cut into strips of 0.5-1 mm, covered with enzyme solution (1.5% cellulase R10
(216016, Yakult pharmaceutical, Tokyo, Japan), 0.4% macerozyme® R10 (202051,
Yakult pharmaceutical, Tokyo, Japan), 0.4 M mannitol, 20 mM KCl, 20 mM
morpholinoethanesulfonic acid (MES) (pH 5.7), 10 mM CaCl2, 5 mM β–mercaptoethanol
and 0.1% BSA (Sigma A-6793)), and incubated overnight in the dark at 21˚C. Protoplasts
were filtered with a 100 µm mesh, and centrifuged for 10 minutes at 80 x g at 4˚C. The
supernatant was removed, replaced with an equal volume of cold washing and incubation
solution (WI) (0.5 M mannitol, 4 mM MES (pH 5.7) and 20 mM KCl) and centrifuged
again for 10 minutes at 80 x g at 4˚C. The solution was then transferred gently onto
flotation medium (0.6 M sucrose, 10 mM MES (pH 5.7) and 20 mM KCl) to remove
debris and centrifuged for 10 minutes at 80 x g at 4˚C. Protoplasts were removed from
the top layer of the flotation medium and transferred to cold WI solution.

2.5.6

Confocal microscopy and image analysis

To visualize protoplasts, Z-stack confocal images of protoplasts were acquired with a
Leica TCS SP2 confocal laser scanning inverted microscope (Leica Microsystems,
Wetzlar, Germany) equipped with a 63X water immersion objective. The surpass module
of Imaris® x64 software (version 7.6.1, Bitplane Scientific Software) was used to
generate 3D reconstructed images and videos. To measure the size and volume of PBs,
the surface module of Imaris software was used to detect separate PBs.
To visualize leaf samples, the abaxial leaf epidermis was imaged with a Leica TCS SP2
CLSM. For the imaging of GFP and chlorophyll autofluorescence, excitation with a
488 nm argon laser was used and fluorescence was detected at 500-525 nm and 630-690
nm, respectively. The excitation for RFP was 543 nm and its emission was recorded at
553-630 nm. Collected images were analyzed with the Leica Application Suite for
Advanced Fluorescence (LAS AF, version 2.3.5) (Leica Microsystem, Germany). To
avoid crosstalk between the fluorescent channels, images were acquired in the sequential
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mode at all times. To visualize whole-mounted tissue, 488 nm argon laser was used to
detect Alexa Fluor® 488 dye, and green fluorescence was detected at 495 to 525 nm.

2.5.7

Recombinant protein quantification

GFP quantification was performed with either fluorometry or immunodot blot as
described by Gutierrez et al. (2013). For Western blot analysis, 3 µg of total soluble
protein

were

resolved

by

10%

sodium

dodecylsulphate-polyacrylamide

gel

electrophoresis (SDS-PAGE) and transferred to polyvinylidene difluride (PVDF)
membrane. The recombinant proteins were detected with the primary mouse anti-c-myc
monoclonal antibody (GenScript, Cat. No. A00864) diluted 1:5000 in blocking solution
and HRP-conjugated goat anti-mouse IgG secondary antibody diluted 1:3000 (Biorad,
Cat. No. 170-6516). Membranes were visualized with the enhanced chemiluminescence
(ECL) detection kit (GE Healthcare, Mississauga, ON, Canada) as described by the
manufacturer. Quantification was performed using TotalLab TL 100 software (Nonlinear
Dynamics, Durham, USA) with intensity analysis of specific bands, with known amounts
of a c-myc-tagged standard protein as a standard.
Quantification of prEPO from N. benthamiana leaf extracts were performed by sandwich
ELISA as described previously (Conley et al., 2009c). At least 4 independent biological
samples were quantified per treatment. Leaf tissue infiltrated with p19 was used as
control.
The concentration of plant recombinant IL-10 was determined by comparison with a
human IL-10 standard curve according to the manufacturer’s instructions (BD
Biosciences, Mississauga, Canada).

2.5.8

Immunocytochemistry

Whole-mounting of N. benthamiana leaves was performed as described by Sauer et al.,
(Sauer et al., 2006). Briefly, pieces of infiltrated and non-infiltrated leaves were fixed in
4% paraformaldehyde (Electron Microscopy Sciences, PA, USA) in PBS supplemented
with 0.1% Triton™ X-100 (Sigma, Cat. No. T-9284), and permeabilized in Driselase
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(Sigma, Cat. No. D-9515) and IGEPAL® (Sigma, Cat. No. CA-630) plus 10% dimethyl
sulfoxide (DMSO) (Sigma, Cat. No. D8418). For immunocytochemistry, samples were
pre-blocked in 3% BSA (Fisher Scientific, Cat. No. BP1600-100), incubated with c-myc
monoclonal mouse antibody (1:1000 dilution) as the primary antibody and donkey antimouse IgG antibody conjugated to Alexa Fluor® 488 dye (1:130 dilution) as the
secondary antibody (Life Technologies, Cat. No. A-21202). Confocal microscopy was
performed as described above.

2.5.9

Statistical analysis

Statistical analysis of the protein body size comparison experiment was performed with
Prism 6 (GraphPad Software, CA, USA). The Kolmogorov-Smirnov test was used to
confirm the normal distribution of data. Since the data were not normally distributed, the
Kruskal-Wallis non-parametric test of variance was used to assess if there were statistical
differences between the median values of different treatments. Other statistical analyses
were performed with SPSS Statistics V 22.0 for Windows (IBM, NY, USA). Depending
on the number of comparisons involved, a student t-test or one-way ANOVA test was
performed followed by Tukey-Kramer’s test to find means significantly different from
one another. A Post-Hoc test was then performed to analyze for significance of mean
difference at 95% confidence intervals (the level of statistical difference was defined as
p < 0.05).

2.6 Appendices
Supplementary Movie 2. 1 Four dimensional (4D) visualization of protein bodies.
Z-stack images of a GFP-ELP infiltrated protoplast were acquired by confocal
microscopy and assembled into a 4D illustration with the Imaris software. Chlorophyll
autofluorescence highlights chloroplasts inside the cell. PBs were detected in the green
channel and the respective information of every PB was exported using the same
software.
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3.1 Introduction
Fusions of Green Fluorescent Protein (GFP) and its derivatives are extremely valuable
tools for examining gene expression, protein and RNA localization, protein-protein
interactions, protein synthesis and degradation, and organelle movement. The
development of photoconvertible fluorescent proteins such as EosFP (Wiedenmann et al.,
2004), Kaede (Ando et al., 2002), KikGR (Tsutsui et al., 2005), Dendra (Gurskaya et al.,
2006), and mCherry (Subach et al., 2009), allowed new questions to be asked concerning
dynamic processes in living cells. However, the use of some photoconvertible proteins
has drawbacks (Adam et al., 2014). For example, non-GFP photoconvertible fluorescent
proteins sometimes exhibit unexpected subcellular localization behavior (Hanson and
Sattarzadeh, 2013). Another issue is the necessity to introduce new transgenes expressing
the photoconvertible proteins into the genotypes of interest. Since many proteins have
already been tagged with EGFP or GFP modified by an S65T mutation, being able to
photoconvert these common forms of GFP would allow the use of existing transgenic
lines to study dynamic changes.
EGFP has been known to photoconvert from green-state to red-emitting state upon
exposure to blue light after excitation with 488 nm illumination under low oxygen
conditions (Elowitz et al., 1997), low oxygen with added flavin adenine dinucleotide
(FAD) (Matsuda et al., 2010) or by added oxidizing agents such as potassium
ferricyanide,

benzoquinone

(BQ)

or

3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl

tetrazolium bromide (MTT). The process of green to red photoconversion is also referred
to as “redding” (Bogdanov et al., 2009). The fluorescence spectra of the photoconverted
species varies depending on the conditions used to catalyze the conversion. The “red”
emission maximum was at 560 nm in the FAD-mediated conversion (Matsuda et al.,
2010), while three peaks were reported (560, 590 and 600 nm) under anaerobic
conditions (no added FAD) (Elowitz et al., 1997). The addition of chemical oxidants (e.g.
BQ or MTT) resulted in 600 nm emissions with the exception of one report of a 675 nm
peak (Saha et al., 2013).
In this chapter, the previously uncharacterized irreversible photoconversion of EGFP
from green-state to red-state is described. Unlike previous studies, the photoconversion of
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EGFP in vitro and in vivo occurs spontaneously with no need for special treatments such
as low oxygen environments or addition of electron acceptors.

3.2 Results
3.2.1

EGFP photoconverts from green to red in the absence of
electron acceptors

While performing photobleaching studies on plant cells labeled with GFP, I made the
unexpected observation that EGFP, mGFP4-T, and GFP modified by an S65T mutation
(Figure 3.1a) can be photoconverted by 405 nm light in vivo without adding electron
acceptors or using special conditions. To verify whether EGFP could be photoconverted
in vitro from its normal green-state to a red-state, irradiation of purified EGFP was
investigated. By using the Zeiss 710 bleaching mode with a 405 nm laser for
photoconversion, rather than 488 nm as used in the previous reports (Bogdanov et al.,
2009; Elowitz et al., 1997), purified EGFP was imaged before and after application of the
405 nm light. The green-state of purified EGFP was imaged with excitation at 488 nm,
and the emission was acquired between 500-525 nm. The photoconverted EGFP (redstate) was monitored using 561 nm excitation and detected between 580-670 nm.
Photoconversion occurred, as demonstrated by the decrease in green fluorescence and the
simultaneous increase in red fluorescence (Figure 3.2a). Study of the emission spectra of
photoconverted EGFP showed a maximum emission peak at around 612 nm when excited
at 561 nm (Figure 3.2b).
Comparison of the absorption spectra of EGFP showed a higher absorption (~ 2.6 times)
at pH 5.0 compared with pH 8.0 at 405 nm (Figure 3.2c). EGFP absorption peaks at 488
nm at pH 8.0, but the red species of EGFP was not excited by the 488 nm light, therefore
the 488 nm illumination could not be used for photoconversion.
Time course comparison of the relative fluorescence of red-state EGFP at different pHs
also indicated an increased yield (~ 2.3 times) of red photo-product at pH 5.0 compared
to pH 8.0 (Figure 3.2d). This finding indicates that cellular compartments with higher
pH may be less suitable for imaging of photoconverted GFP. The photoconversion appears to
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Figure 3. 1 Comparison of different strains of GFP variants and schematic representation
of constructs.
(a) Alignment of the coding sequence of the GFP variants used for photoconversion. The
alignment was created using GeneDoc (http://www.nrbsc.org/gfx/genedoc/). (b)
Schematic representation of the GFP transgenes used in photoconversion experiments.
Pr1b-SP, secretory signal peptide from the tobacco pathogenesis-related protein 1; EGFP,
enhanced green fluorescent protein; L, linker (GGGS)3; KDEL, endoplasmic reticulum
retrieval signal peptide; HttQ103, exon 1 of human Huntington polyQ gene; Cytosolic
mGFP4-T in tobacco cell culture and cytosolic S65T-GFP in Drosophila gut cells. In
cytosolic mGFP4-T, V (Valine) was replaced by A (Alanine), and Q (Glutamine) was
replaced by R (Arginine) compared with EGFP. In cytosolic S65T-GFP, L (Leucine) was
replaced by F (Phenylalanine) compared with EGFP.
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Figure 3. 2 Photoconversion of purified EGFP in vitro.
(a) Typical pre- and post-photoconversion images of a thin (~ 10 μm) layer of 30 μM
EGFP using 405 nm excitation. Bar 50 μm. (b) Emission spectra of photoconverted redstate EGFP acquired in 5 nm bandwidth intervals. (c) Absorption spectra of EGFP (~ 2
μM) at pH 5.0 and pH 8.0. EGFP absorption at 405 nm is approximately 2.6 times higher
in pH 5.0 compared to pH 8.0. (d) Time course comparison of the increase in red
fluorescence with successive 405 nm irradiations within the region of irradiation (ROI)
shown in white. EGFP (30 mM) was subjected to a sequence of 10 “bleach” iterations
over the ROI. Plotted data points are the average pixel values across the entire field of
view which estimates the total photo-product produced. Error bars represent the standard
error of the mean of three trials at pH 5.0 and two at pH 8.0.
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be irreversible since the red-state EGFP was visible several hours after photoconversion
in the in vitro experiments (data not shown).

3.2.2

EGFP photoconversion, a valuable tool for protein tracking in
vivo

To determine whether GFP could be converted from green to red in vivo, a
photoconversion experiment was performed first in transgenic tobacco cells in which
GFP was localized in the cytoplasm (Köhler et al., 1997). Converting GFP from a greento a red-state resulted in rapid diffusion of the red form within the plant cytoplasm. In
less than 3 seconds after irradiation, red-GFP was detected in the red channel. The
photoconverted red-GFP then diffused through the whole cell and was readily visible
throughout the cell within 2 minutes (Figure 3.3a and Supplementary Movie 3.2).
Fluorescence intensity was measured in the region of irradiation (ROI) indicated by a
white circle. There is a noticeable decrease in intensity of the green signal and a
concomitant increase in intensity of the red signal, which is an indication of
photoconversion from green to red (Figure 3.3b).
The photoconversion of EGFP was also observed in other eukaryotic model organisms,
including Drosophila and rat cells. A Drosophila line in which S65T-GFP was expressed
in gut cells from 3rd instar larvae (Reichhart and Ferrandon, 1998), and a rat PC12 cell
line expressing EGFP fused to exon 1 of the human Huntington polyQ (HttQ103) gene
(Aiken et al., 2004) were obtained (Figure 3.1b). Upon irradiation of Drosophila and rat
cells using conditions similar to plant cells, photoconversion from green- to red-state was
observed (Figure 3.3c-d).
In addition to photoconversion of stably transformed cells, photoconversion was also
observed in Nicotiana benthamiana epidermal leaf cells transiently expressing EGFP.
Irradiation of a small area of the apoplast-targeted EGFP resulted in instant
photoconversion of the protein localized in the extracellular space between the cells. To
track the photoconverted protein and avoid photobleaching, irradiation of ROI was
performed with time intervals (every 42 seconds in this case) to allow replacement of
photoconverted protein with newly secreted protein in the ROI (Figure 3.4a). As shown
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Figure 3. 3 Photoconversion of GFP from green to red state in vivo.
Single snapshots from pre-photoconversion and post-photoconversion are shown.
Photoconversion was performed at 50% laser power and 30 iterations, except rat cells
were irradiated at 70% power with 30 iterations. (a) Tobacco cell suspension culture in
which GFP is targeted to the cytosol. (b) Changes in fluorescence intensity in the region
of irradiation (ROI) in “(a)” over time indicate increasing red and decreasing green
fluorescence. (c) Drosophila gut cells from 3rd instar larvae expressing S65T-GFP. (d)
Rat PC12 cells expressing EGFP fusion to exon 1 of human HttQ103 gene. Bar 10 μm.
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Figure 3. 4 EGFP photoconversion occurs in N. benthamiana cells transiently expressing
EGFP targeted to apoplastic space.
(a) Secretory EGFP targeted to the apoplastic space between the cells photoconverts from
green to red upon excitation with 405-nm laser at 35% of laser power and 20 iterations.
The photoconverted red protein travels within the apoplastic space between the cells. (b)
Change in fluorescence intensity in the ROI shown with a white circle in (a) over time
indicate increasing red and decreasing green fluorescence. Grey bars represent the
irradiation times. Bar 20 µm.
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in Figure 3.4b, a significant drop in fluorescence intensity of green-state EGFP happened
simultaneously with a significant increase in the fluorescence intensity of red-state EGFP.
Trafficking of new EGFP to the ROI is confirmed by the increase in green fluorescence
intensity between irradiations while trafficking of red-state EGFP out of ROI is shown by
the decrease in the amount of fluorescence intensity of red-state EGFP (Figure 3.4b).
Upon photoconversion of a small area of the ER-targeted EGFP, the green signal
instantly switched from green to red and spread throughout the ER within 5 minutes to
areas more than 80 µm away from the irradiated area (Figure 3.5a, Supplementary Movie
3.3). A similar observation was made with irradiation of a small area of a cell expressing
cytosolic EGFP in which the signal spread across the cytosol within 7 minutes after
irradiation (Figure 3.5b, Supplementary Movie 3.4). On the other hand, chloroplasts in
transplastomic tobacco cells expressing EGFP was completely photoconverted upon
irradiation, but the photoconverted red-state EGFP did not fill the whole chloroplast or
move out of the chloroplast, neither was the green-state EGFP replaced in the ROI
(Figure 3.5c).

3.3 Discussion and conclusion
The results presented in this chapter describe a previously unnoticed ability of GFP
which enables regional, non-invasive photoconversion of GFP without the need for
providing a low oxygen environment. Because many proteins have already been tagged
with GFP in transgenic cells, being able to photoconvert GFP, rather than other
photoconvertible fluorescent proteins, would allow the use of existing transgenic lines for
studies of dynamic processes in living cells.
GFP photoconversion described here was successfully tested in a range of model
organisms, such as Drosophila, rat, tobacco cell culture and N. benthamiana leaf
epidermal cells, in different subcellular locations such as the cytosol, ER, apoplast and
chloroplast. By carefully selecting the conditions to avoid photobleaching, the flow of
photoconverted molecules in several subcellular locations of leaf cells were observed.
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Figure 3. 5 EGFP photoconversion occurs in N. benthamiana cells transiently expressing
EGFP.
(a) ER-targeted EGFP photoconverts from green to red upon excitation with 405-nm laser
at 60% of laser power and 100 iterations. The photoconverted red protein travels within
the ER network of the cell. (b) Cytosolic EGFP photoconverts and spreads within the
cytosolic space of the cell. Photoconversion was performed at 70% of laser power and 30
iterations. (c) Photoconversion of a chloroplast in transplastomic tobacco leaf cells
expressing EGFP. The photoconverted signal does not spread to neighboring
chloroplasts. Photoconversion was performed at 100% of laser power and 90 iterations.
White circles represent the irradiated area. Bar 20 µm.
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The absorption spectrum of EGFP at pH 5.0 was found to be higher than at pH 8.0,
suggesting that photoconversion may be more easily detectable in cellular compartments
with lower pH values such as the trans Golgi network (TGN) (pH ~ 6.1) and vacuole (pH
~ 6.0) in plant cells and TGN (pH ~ 5.9), late endosome (pH ~ 6.0) and lysosome (pH ~
5.5) in animal cells (Martiniere et al., 2013a; Martiniere et al., 2013b). On the other hand,
photoconversion in organelles with higher pH values might not be easily performed. For
instance, to fully photoconvert the EGFP in the chloroplast of transplastomic tobacco,
high laser power (100%) was required, and the photoconverted protein was not visible in
the whole chloroplast neither showed any movement within or out of the chloroplast.
This might have been due to the high pH of chloroplast stroma (pH ~ 8.0) (Shen et al.,
2013) or due to the photobleaching of the protein since photoconversion of chloroplasts
was only observed at full laser power (100%) and at high iterations (n=90).
Photoconversion of EGFP offers several advantages compared to other non-GFP-based
photoconverting proteins. For instance, transgenic Arabidopsis thaliana plants expressing
cytosolic mEosFP grown in bright fluorescent white light, up to 25% of hypocotyl
epidermal cells contained red nuclei (due to auto-photoconversion) without any
intentional photoconversion (Mathur et al., 2010). Another concern involved with the use
of mEosFP is the partial photoconversion under short exposure times. Photoconversion of
mEosFP happens in a concentric manner, therefore producing variability in shades which
is problematic since both partial photoconversion and co-localization of the green and
red, will produce yellow hues (Mathur et al., 2010).
Furthermore, the maximum emission peak of the photoconverted GFP (red-state) is at
612 nm, which is different from that of the most commonly used photoconvertible
proteins such as mEOS2 (red-state) at 584 nm and Dendra2 (red-state) at 573 nm. This
enables the imaging of red-state EGFP with other fluorescent proteins such as EBFP,
ECFP, EYFP with maximum emission peaks at 445, 476, 527 respectively, and many
other fluorescent proteins. In conclusion, my results demonstrate that GFP
photoconversion can be added to the cell biologist’s toolkit for monitoring protein
dynamics.
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3.4 Experimental procedures
3.4.1

Construct design and transgenes

The GFP variants used in this study are shown in figure 3.1b. ER-EGFP and cytosolicEGFP plant expression vectors (Conley et al., 2009), PC12 cell line expressing HttQ103EGFP generously provided by Dr. R. Cumming, University of Western Ontario (Aiken et
al., 2004), and the Drosophila strain expressing S65T-GFP (Reichhart and Ferrandon,
1998) were previously published.

3.4.2

Strains used and culture conditions

For transient expression experiments, 7-week old N. benthamiana plants grown at 22°C
with a 16 hour photoperiod at 110 μmol m-2 s-1 were used. Plants were fertilized with the
water soluble fertilizer (N:P:K=20:8:20) (Plant Products, Brampton, ON, Canada) at 0.25
g/L. Agrobacterium tumefaciens strain EHA105 containing the cytosolic-EGFP and EREGFP were used for infiltration as described by Conley et al. (2009). Rat PC12 cells
were grown in Dulbecco’s modified Eagle’s medium (DMEM) and supplemented with
10% FBS and 1% penicillin/streptomycin at 37°C in 5% CO2. To induce the expression
of HttQ103-EGFP, cells were treated with 2.5 μM tebufenocide (Sigma, St. Louis, MI) for
24 to 48 hours. Tobacco cell suspensions were grown in NT1 medium with regular
shaking at 22°C (Reichhart and Ferrandon, 1998). Drosophila larvae were grown at room
temperature in standard corn meal agar.

3.4.3

Microscopy and imaging

A Zeiss LSM 710 confocal microscope equipped with a 10X dry or 40X water immersion
objective was used for the imaging and photoconversion of GFP. The Zeiss automated
bleaching mode was used for photoconversion. A 405 nm laser (2.5 mW at 100% power
setting) was used to photoconvert. The photoconversion was monitored using 488/561
nm excitation with the emission collected between 500-525 nm (green) and 580-670 nm
(red). To establish the baseline fluorescence intensity and distribution, five prephotoconversion scans (∼4 sec) were recorded before starting the photoconverting
irradiation. Images were recorded and processed using Zeiss Zen software. In cells with
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high expression levels of GFP, lower laser powers (20-30% corresponding to ~ 500 μW)
and shorter exposure times were used for photoconversion. In cells with lower GFP
expression, sequential and simultaneous imaging of cells during photoconversion was
used in order to prevent photo-damage in the cells under irradiation.
To track the in vivo movement of proteins, multiple irradiations with time intervals (from
seconds to minutes) were used to follow trafficking of the photoconverted protein and to
photoconvert newly synthesized/trafficked proteins in the irradiated area (Figure 3.2,
Supplementary Movie 3.3, 3.4).

3.5 Appendices
Supplementary Movie 3. 1 Time-lapse series demonstrating photoconversion of purified
EGFP.
Supplementary Movie 3. 2 Time-lapse series demonstrating photoconversion of a
tobacco suspension cell.
Tobacco suspension cell culture labeled with S65T-GFP in the cytoplasm undergoing
photoconversion from the green state to the red state.
Supplementary Movie 3. 3 Time-lapse series demonstrating photoconversion and
trafficking of ER-targeted EGFP in a N. benthamiana epidermal cell.
Confocal imaging of cells expressing ER targeted EGFP in N. benthamiana was
performed to demonstrate the photoconversion and trafficking of EGFP in the ER
network. The ROI (shown with white circles) was irradiated with 405 at 60% of laser
power and 100 iterations every 30 seconds.
Supplementary Movie 3. 4 Time-lapse series demonstrating photoconversion and
trafficking of cytosolic-targeted EGFP in a N. benthamiana epidermal cell.
Confocal imaging of cells expressing cytosolic EGFP in N. benthamiana was performed
to demonstrate photoconversion and trafficking of EGFP in the cytosol. The ROI (shown
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with white circles) was irradiated with 405 at 70% of laser power and 30 iterations every
22 seconds.
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4.1 Introduction
Plants have been accepted as a growing platform for production of a wide range of
recombinant proteins including vaccines, antibodies, pharmaceuticals and industrial
enzymes. The popularity of plants as “green bioreactors” is due to advantages such as
scalability, cost and safety compared to other systems. Moreover, plants offer other
benefits, including the ability to introduce post-translational modifications such as
disulfide bonds and glycosylation and the low risk of mammalian pathogen
contamination (Egelkrout et al., 2012).
Transient expression in leaves of Nicotiana benthamiana has become one of the most
popular platforms for recombinant protein production and offers several advantages
including flexibility and rapid scalability for protein production (D'Aoust et al., 2010).
Despite the advantages of this system, two major problems still need to be resolved: low
production yield of some short-lived proteins and lack of efficient purification methods
(Conley et al., 2011a). Introduction of fusion tags has had a significant impact in tackling
both these problems. Fusion-based approaches were shown to improve protein yield,
prevent proteolysis, increase solubility and stability of the recombinant proteins and ease
the isolation and purification process of the target proteins (Tremblay et al., 2011). Zera®,
elastin-like polypeptides (ELP) and hydrophobins (HFBI) fusions have been recently
used for recombinant protein production in plants (Conley et al., 2011a; Khan et al.,
2012). These three tags share a number of common features, including increased
accumulation levels of their fusion partners, compatibility with large-scale purification
methods, and induction of the formation of round structures called protein bodies (PB)
usually found in seeds. PBs are endoplasmic reticulum (ER) derived organelles involved
in folding, assembly and stabilization of seed proteins during seed development (Torrent
et al., 2009b).
Zera® is derived from the N-terminal region of γ-zein, a prolamin usually found in maize.
Zera consists of a non proline rich region with a Cys-Gly-Cys motif, a proline rich region
containing eight Pro-Pro-Pro-Val-His-Leu repeats, and a proline-X sequence with four
cysteine residues. Cysteine residues enable the inter-molecular disulfide bond formation
between Zera molecules and the amphipathicity of the (PPPVHL)8 region helps the self-
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assembly of Zera molecules, both of which are necessary for Zera PB formation (LlopTous et al., 2010; Torrent et al., 2009b). Zera-induced PBs have been reported in several
expression systems including mammalian cultured cells (Chinese hamster ovary), plant
leaves (Nicotiana tabacum), fungi (Trichoderma reesei), and insect cells (Spodoptera
frugiperda (Sf9)) (Torrent et al., 2009a). Zera-fused proteins can be purified using a
simple density centrifugation method. Several recombinant proteins have been produced
and purified using Zera fusions including epidermal growth factor (up to 0.5 g/kg LFW),
human growth hormone (up to 3.2 g/kg LFW), and a Streptomyces derived xylanase (up
to 1.6 g/kg LFW) (Llop-Tous et al., 2010; 2011).
ELPs are composed of repeating pentapeptides Val-Pro-Gly-Xaa-Gly similar to repetitive
pentapeptides found in mammalian elastin proteins. The guest amino acid (Xaa) can be
any amino acid except proline (Urry and Parker, 2002). The size of ELP repeats can vary
based on the experimental design (Conley et al., 2009a). ELP-fused proteins can be
purified using inverse transition cycling (ITC), a non-chromatographic protein
purification method (Meyer and Chilkoti, 1999). ELP fusions have been successfully
used to increase accumulation levels of interleukin-10 (up to 4.5% TSP) and green
fluorescent protein (GFP) (up to 11% TSP) in N. benthamiana leaves (Conley et al.,
2009b). Similar to Zera, the ELP tag induces PB formation and allows higher
accumulation of recombinant proteins (Conley et al., 2009b).
Hydrophobins are a family of amphipathic proteins found in filamentous fungi. Eight
cysteine residues positioned in a special pattern throughout the hydrophobin sequence are
responsible for the formation of four intramolecular disulfide bridges which maintain the
structural stability of the molecule. This enables hydrophobins to self-assemble at
hydrophilic-hydrophobic interfaces (Joensuu et al., 2010a). Similar to ELP,
hydrophobin’s properties can be exploited for purification using a surfactant-based
aqueous two-phase separation system (ATPS) (Linder et al., 2004). HFBI was used as a
fusion tag to increase the accumulation levels of glucose oxidase (GOx), an enzyme that
could not be produced in other conventional expression systems (Bankar et al., 2009;
Joensuu et al., 2010b). Accumulation levels of GFP-HFBI reached up to 51% TSP when
transiently expressed in N. benthamiana leaves, and the recombinant protein fusion was
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found in PBs (Joensuu et al., 2010a). Interestingly, the formation of PBs was correlated
with a reduction in tissue necrosis, and it was hypothesized that PBs protect the leaf
tissue from toxicity of highly expressed proteins (Conley et al., 2011b; Joensuu et al.,
2010a).
The process by which PBs are induced by the fusion tags have been studied to some
extent but due to the complexity of this process many questions remain unanswered. It
has been shown that recombinant protein concentration is a critical element for PB
formation in transgenic N. tabacum leaves, and by transient expression in N.
benthamiana leaves. A threshold accumulation level of the recombinant protein (at 0.2%
of total soluble protein) was found to be required for PB initiation (Gutiérrez et al., 2013;
Llop-Tous et al., 2010) (Chapter 2). PB formation is shown to be a non-selective
mechanism and proteins targeted to the secretory pathway are passively sequestered to
ELP- and HFBI-induced PBs. It has also been shown that fusion tags are not necessarily
required for PB formation but their presence affects the size and distribution patterns of
PBs (Chapter 2). Interestingly, PBs induced by the Zera, ELP and HFBI fusion tags are
not exactly similar. The Zera-induced PBs are more electron dense compared to ELP or
HFBI PBs (Conley et al., 2009b; Joensuu et al., 2010a; Torrent et al., 2009b), and ELPinduced PBs are larger in size compared to HFBI or Zera PBs (Chapter 2). The
similarities and differences between the various fusion-tag-induced PBs are not fully
understood and require further characterization.
In this study I compared PBs induced by Zera, ELP and HFBI fusion tags. I localized
secretory and ER-targeted proteins to Zera-induced PBs and found that localization
patterns are different from ELP- and HFBI-induced PBs. I confirmed the ER origin of all
the fusion-tag-induced PBs. My results show that ELP- and HFBI-induced PBs are not
terminally stored cytosolic organelles but actively communicating with the ER.
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4.2 Results
4.2.1

Secretory and ER-targeted proteins are sequestered into
Zera-induced PBs, but their localization pattern is different
from ELP- or HFBI-induced PBs

A proteomic study of Zera-induced PBs showed the presence of secretory pathway
proteins in PBs (Joseph et al., 2012). I showed in chapter 2 that PBs induced by ELP and
HFBI also can capture secretory and ER-targeted proteins. This property of PBs was used
as a tool to increase accumulation levels of low-accumulating proteins such as
erythropoietin (EPO) and interleukin-10 (IL-10).
To test if recombinant proteins can also be targeted into Zera-induced PBs, I coexpressed secretory GFP and ER-targeted GFP with Zera-DsRed. When expressed alone,
secretory GFP localized to the apoplastic space between the cells (Figure 4.1a), ERtargeted GFP highlighted the ER and induced the formation of very small PBs along the
ER network (Figure 4.1b), and Zera-DsRed gave rise to distinct PBs (Figure 4.1c). Upon
co-expression of secretory GFP and Zera-DsRed, secretory GFP was found in Zerainduced PBs, but it did not mix with Zera-DsRed which localized to the center of PBs;
GFP was seen at the periphery of PBs (Figure 4.1d-f). Co-expression of ER-targeted
GFP and Zera-DsRed showed a similar pattern (Figure 4.1g-i) (Supplementary Movie
4.1). In these co-expression experiments, PBs were aligned along the ER network. This
pattern is noticeable in the 4D compilation of Z-stack images (Supplementary Movie
4.1).
I showed in chapter 2 that co-expressing EPO with GFP-ELP or GFP-HFBI increased
accumulation levels of EPO. To test if co-expression with Zera-DsRed would result in a
similar increase, I co-expressed EPO with Zera-DsRed and found that accumulation of
EPO was reduced (Figure 4.2).
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Figure 4. 1 Secretory and endoplasmic reticulum-targeted GFP are sequestered in Zera
induced PBs.
(a) Secretory GFP highlights the apoplastic space between the cells. (b) ER-targeted GFP
forms small PBs along the ER network. (c) Zera-DsRed induces the formation of PBs. (df) Co-expression of secretory GFP and Zera-DsRed results in sequestration of secretory
GFP into Zera-DsRed PBs. (g-i) Co-expression of ER-targeted GFP and Zera-DsRed
results in sequestration of GFP into Zera-DsRed PBs. All images were acquired in
sequential mode. Bar, 10 µm.
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Figure 4. 2 Co-expression of erythropoietin (EPO) and Zera-DsRed.
Enzyme-linked immunosorbent assay (ELISA) of recombinant EPO was used for
quantification of EPO in agroinfiltrated N. benthamiana leaves. Each column represents
the mean value of 4 biological replicates. Columns denoted with the same letter were
not significantly different (p < 0.05) using one-way ANOVA. The error bars represent
the standard deviation of the mean.
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4.2.2

ELP- and HFBI-fused proteins can be targeted to the same
PBs unlike Zera-fused proteins

The previous comparison of PBs induced by ELP and HFBI showed that ELP-induced
PBs were larger in size compared to HFBI-induced PBs (Chapter 2). Zera-induced PBs
were shown to range mostly between 0.5 and 1 µm (and in some cases as large as 2 µm)
(Joseph et al., 2012), which is smaller than the average size ELP-induced PBs.
To characterize the relationship or distinctness of Zera-, ELP- and HFBI-induced PBs coexpression analyses were performed. When GFP-ELP, RFP-HFBI, GFP-HFBI or ZeraDsRed were expressed alone, each induced the formation of PBs (Figure 4.3a, 4.3b, 4.3c,
and 4.3d, respectively). ELP-induced PBs were larger in size compared to HFBI- or Zerainduced PBs as expected. Upon co-expression of GFP-ELP and RFP-HFBI, both proteins
co-localized into the same PBs (Figure 4.3e-g). This result suggests that the two fusioninduced PBs might share a similar origin of sequestering proteins.
Unlike ELP and HFBI, co-expression of either fusion tag with Zera did not result in colocalization of the proteins into the same PBs, and gave rise to the formation of separate
PBs. This can be easily seen as the gaps seen between GFP-HFBI PBs were filled with
Zera-DsRed PBs (Figure 4.3h-j) (Supplementary Movie 4.2). Co-expression of GFP-ELP
and Zera-DsRed proteins resulted in the formation of large GFP-ELP-induced PBs and
smaller distinct Zera-DsRed-induced PBs (Figure 4.3k-m) (Supplementary Movie 4.3).

4.2.3

ELP-, HFBI- and Zera-induced
surrounded by ER membrane

protein

bodies

are

Previous reports have suggested an ER origin for the fusion-tag-induced PBs. ELP, HFBI
and Zera were shown by transmission electron microscopy to be surrounded with a
membrane studded with ribosomes therefore assumed to be an ER-derived membrane
(Conley et al., 2009b; Joensuu et al., 2010a; Joseph et al., 2012). Joseph et al., also
claimed the existence of an ER membrane around Zera-induced PBs. To ascertain if PBs
induced by ELP, HFBI and Zera share an ER origin, I co-expressed RFP-ELP, RFPHFBI and Zera-DsRed with the same construct used by Joseph et al. (2012) in which an
ER transmembrane domain (C-terminus) of squalene synthase 1 (SQS1) of Arabidopsis
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Figure 4. 3 Co-expression of ELP-, HFBI-, and Zera-fused fluorescent proteins.
(a) GFP-ELP promotes the formation of large PBs, (b) RFP-HFBI forms clusters of PBs,
(c) GFP-HFBI forms clusters of PBs, and (d) Zera-DsRed induces the formation of PBs
when expressed alone. (e-g) Co-expression of GFP-ELP and RFP-HFBI results in
co-localization of the recombinant proteins into the same PBs. (h-j) Co-expression of
GFP-HFBI and Zera-DsRed forms separate PBs. (k-m) Co-expression of GFP-ELP and
Zera-DsRed forms distinct PBs. All images were acquired in sequential mode. Bar, 10
µm.
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was fused to GFP (GFP-SQS1) at the N-terminus facing the cytosolic side of the ER
membrane. The C-terminus region of SQS is comprised of a highly hydrophobic amino
acid sequence, which helps to anchor the protein into the ER membrane (Kribii et al.,
1997). GFP-SQS highlights the ER membrane when expressed alone (Figure 4.4a), and
RFP-ELP (Figure 4.4b), RFP-HFBI (Figure 4.3b) and Zera-DsRed (Figure 4.3d) induced
the formation of PBs. Upon transient co-expression of RFP-ELP, RFP-HFBI and ZeraDsRed with GFP-SQS1, PBs were surrounded with a distinctive ER membrane
highlighted by GFP-SQS1 (Figure 4.4c-e, f-h, i-k). In cases where several PBs were
aligned side by side, the ER membrane showed a continuous (uninterrupted) pattern
around each PB. It is also important to note that the membrane surrounding PBs appears to
be continuous with the ER surrounding the cluster of PBs (Figure 4.4e, 4.4h, and 4.4k).

4.2.4

Protein bodies communicate with one another in vivo

The above results indicating the presence of an ER membrane around PBs that may be
connected to the ER network prompted me to investigate if PBs completely bud off and
leave the ER as terminally stored cytosolic organelles or if they remain connected with
the ER, allowing them to exchange their content with other PBs and the surrounding ER.
Co-expression of YFP-KDEL with Zera-induced PBs previously had shown the
localization of YFP to the periphery of Zera-induced PBs. Photobleaching of YFP in
these PBs by using the fluorescence recovery after photobleaching (FRAP) technique
resulted in rapid recovery of YFP, within 80 seconds, indicating the connection of Zera
PBs with the ER (Joseph et al., 2012). Conley et al. (2009b) also had shown the recovery
of GFP-ELP-induced PBs after photobleaching within 5 minutes suggesting the
trafficking of GFP from other parts of the cell to the bleached PB. Since the FRAP
technique used in these experiments did not allow visualization of the photobleached
protein, I used instead photoconversion, as described in chapter 3, which enabled me to
track the photoconverted protein and also measure the fluorescence recovery with the
newly trafficked protein into the irradiated area. Therefore, I used GFP fusions of HFBI
and ELP to track the protein’s movement once it was photoconverted in a specific PB or
group of PBs (Figure 4.5 and 4.6).

100

Figure 4. 4 Protein bodies are surrounded with an endoplasmic reticulum-derived
membrane.
(a) GFP-SQS1 highlights the ER membrane. The large circle highlights the nucleus. (b)
RFP-ELP induces PBs clustered together. (c-e) Co-expression of GFP-SQS1 and RFPELP results in the formation of RFP-ELP PBs surrounded with the ER membrane
highlighted by GFP-SQS1. (f-h) Co-expression of RFP-HFBI and GFP-SQS1 results in
PBs surrounded by GFP-SQS1. (i-k) Co-expression of Zera-DsRed and GFP-SQS1
results in the formation of Zera-DsRed PBs surrounded by GFP-SQS1. All images were
acquired in sequential mode. Bar, 5 µm.

101

102

Figure 4. 5 Trafficking of proteins between GFP-HFBI-induced protein bodies.
(a-c) GFP-HFBI-induced PBs form clusters and can only be visualized in the green
channel before photoconversion. The yellow circle represents the region of irradiation
(ROI-1). Regions of interest (ROI 2-4) are shown in white. (d-f) Upon irradiation of
ROI-1, the GFP in PBs within the circle photoconverts to red and starts spreading into
neighboring PBs. (g-i) Within approximately 3 minutes from the first irradiation, GFP
fluorescent recovers at ROI-1 and the red signal is spread to neighboring and distant PBs
more than 10 µm away from ROI-1. (j-l) After multiple irradiations (with 3 minute time
intervals) of ROI-1, sufficient red fluorescence is produced that shows the trafficking of
the photoconverted protein from ROI-1 to ROI-4 and PBs further away (approximately
40 µm from ROI-1). (m-o) 3D representation of the PBs from a 90 degree perspective.
PBs irradiated in ROI-1 are highlighted in yellow. ROI-4 is shown with a square. PBs
between ROI-1 and ROI-4 are linked with a chain of PBs at a different focal plane within
the cell. (p-s) Changes in fluorescence intensity of the green and red signal in ROI-1 (p),
ROI-2(q), ROI-3 (r) and ROI-4 (s). Black bars indicate the irradiation period. All images
were acquired in sequential mode. Bar, 10 µm.
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Irradiation of GFP-HFBI PBs resulted in immediate photoconversion of the irradiated
PBs and their neighboring PBs in and around the region of irradiation-1 (ROI-1) (Figure
4.5a-f). This is also demonstrated by the sudden decrease of the green fluorescence and
the simultaneous increase of red fluorescence at ROI-1 (Figure 4.4p). Photoconverted
protein (red-state) continued to spread into the surrounding PBs. Approximately 3
minutes after the first irradiation, fluorescence intensity of the red signal at the ROI-1
was decreased by half (Figure 4.5p) as the photoconverted red signal was trafficked to the
adjacent PBs whereas GFP increased, presumably due to trafficking to the ROI-1 (Figure
4.5g-i and 4.5p). I noticed that by repetitive irradiation of GFP trafficked to ROI-1 with 3
minutes intervals more photoconverted protein (red signal) could be produced which
enabled me to track the signal as it travelled to the neighboring (ROI-2) and distant PBs
(ROI-4) located more than 20 µm away from ROI-1 (Figure 4.5j-l, and 4.5s)
(Supplementary Movie 4.4). It is important to note that the GFP at ROI-1 recovered
gradually after every irradiation (Figure 4.5p). This recovery can be due to trafficking of
GFP from neighboring PBs as shown in ROI-2 (Figure 4.5q) in which GFP gradually
decreased over time and was replaced with the red signal coming from the ROI-1.
Interestingly, photoconverted protein only travelled to other PBs and through the ER. A
perfect example is shown by appearance of the red signal in PBs at ROI-4, which did not
seem to be connected to ROI-1. I noticed, however that PBs at ROI-4 were linked to
ROI-1 PBs through a chain of PBs located in a different focal plane (Figure 4.5m-o)
(Supplementary Movie 4.5). Considering no changes in neither green nor red
fluorescence intensities at ROI-3, located in the area between ROI-1 and ROI-4 (Figure
4.5 a-l and 4.5r), I conclude that trafficking of proteins between PBs only happens
through the ER connecting PBs.
Next I tested the possibility of trafficking of proteins among ELP-induced PBs (Figure
4.6). The ROI-1 in this case was much smaller than the large PB I irradiated (Figure 4.6af). Interestingly, upon irradiation of ROI-1, the entire PB photoconverted to red (Figure
4.6e) (Supplementary Movie 4.6) suggesting the high mobility of GFP-ELP within PBs
similar to what was previously reported (Conley et al., 2009b). The photoconverted
signal gradually spread to neighboring PBs (ROI-2) while the green at ROI-1 recovered
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Figure 4. 6 Trafficking of proteins between ELP-induced protein bodies.
(a-c) GFP-ELP-induced PBs form clusters and can only be visualized in the green
channel before photoconversion. The yellow circle represents the region of irradiation
(ROI-1). Regions of interest (ROI 2-4) are shown in white. (d-f) Photoconversion of the
whole PB upon irradiation of a specific region within PB. (g-i) Spread of the
photoconverted red signal from ROI-1 into neighboring (ROI-2) and distant (ROI-4) PBs
within 2.3 minutes. (j-l) After multiple irradiations (with 2.3 minute time intervals) of
ROI-1, sufficient red fluorescence is produced that shows the trafficking of the
photoconverted protein from ROI-1 to other PBs. (m-p) Changes in fluorescence intensity
of the green and red signal in ROI-1 (m), ROI-2(n), ROI-3 (o) and ROI-4 (p). Black bars
indicate the irradiation period. All images were acquired in sequential mode. Bar, 10 µm.
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within approximately 2 minutes (Figure 4.6g-i and m-n). I repeated the photoconversion
of ROI-1 with 2.3 minute intervals and monitored the trafficking of the red signal into
neighboring (ROI-2) and distant (ROI-4) PBs (Figure 4.6j-l, n and p). I also noticed a
sudden minor drop in the green fluorescence intensities at ROI-2 and ROI-4 upon
irradiation of ROI-1 (Figure 4.6n and 4.6p, respectively). This might be due to immediate
trafficking of GFP to the photobleached area at ROI-1 from the other PBs. Monitoring
the fluorescence intensity at ROI-3 showed no changes of the green or red signal and
therefore confirms the trafficking of the photoconverted protein amongst the PBs and not
through the cytoplasm (Figure 4.6a-l and 4.6o).
To understand if protein trafficking occurs via PBs or if it occurs through the ER network
I analyzed 3D images generated by Z-stacks of GFP-ELP acquired 45 minutes postphotoconversion (Figure 4.7). As expected, the red signal was observed in all the PBs
clustered together at, above and below the focal plane at which the photoconverted PB
was located (Figure 4.7b). I also noticed a number of PBs located away from the cluster
of PBs which also turned red (denoted as 1 and 2 in Fig 4.7a-d) (Supplementary Movie
4.7). A high magnification 3D image of these PBs showed that they are surrounded by
the ER network, which was continuous with the ER network around the cluster of PBs. I
could only visualize the ER network in the green channel since the photoconverted red
was not bright enough to highlight the ER (Figure 4.7c-d). It is likely that the ER works
as a bridge between the cluster of PBs and the PBs located away from the cluster.

4.3 Discussion
4.3.1

Proteins targeted to the secretory pathway are sequestered
passively into Zera-induced PBs

Previous proteomic analysis of Zera-induced PBs had shown the presence of ER resident
proteins, such as Bip, calnexin and calreticulin, and secretory proteins such as cell wall
proteins in these PBs (Joseph et al., 2012). In agreement with these results, we found
that upon co-expression of secretory GFP or GFP-KDEL with Zera, GFP was
sequestered into Zera-induced PBs but mainly localized at the periphery of PBs.
Interestingly, this pattern was different from what was previously seen by co-expression
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Figure 4. 7 Protein bodies communicate with one another through the endoplasmic
reticulum.
(a). 3D visualization of GFP-ELP PBs in the green channel. The region of irradiation
(ROI) is shown by a yellow sphere. PBs marked as 1 and 2 are located away from the
ROI and the cluster of PBs and connected to the rest of PBs only through the ER network
shown with arrows. (b). 3D visualization of photoconverted GFP-ELP in the red channel.
PBs marked as 1 and 2 photoconverted to red even though located far from the ROI. (c).
Merged image of the green and red channels. (d). Close-up of the dotted square area in
(c). Arrows point to the ER network. All images were acquired in sequential mode. Bar,
10 µm.
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of secretory or ER-targeted GFP with ELP- or HFBI-induced PBs in which the GFP was
evenly distributed throughout the PBs (Chapter 2). Considering that both secretory GFP
and GFP-KDEL ended up in Zera-induced PBs, even though localized to the periphery of
PBs, I conclude that proteins targeted to the secretory pathway with a Pr1b signal peptide,
are sequestered passively into Zera-induced PBs. It is important to notice that the
physico-chemical properties of Zera protein seem to prevent other recombinant proteins
from penetrating into the core of PBs. This observation is in agreement with the study of
molecular dynamics of Zera by Llop-Tous et al. (2010) in which they proposed that Zera
molecules exhibit a sticklike conformation, and that the amphipathicity of the (PPPVHL)8
repeat regions of Zera imposes lateral protein-protein interaction among Zera molecules
and therefore hydrophobic packing of Zera-PBs (Llop-Tous et al., 2010). This might be
the reason why the GFP molecules were pushed away from the core of Zera PBs and seen
as circles surrounding Zera-DsRed.

4.3.2

Co-expression of low accumulating proteins with Zerainduced PBs is not as efficient as with ELP- or HFBI-induced
PBs

Co-expression of proteins targeted to the secretory pathway with PB-inducing fusion tags
such as ELP and HFBI was found to increase the accumulation levels of low
accumulating proteins (Chapter 2) (Joensuu et al., 2014). It is assumed that PBs prevent
recombinant protein degradation and also protect the cell from potential toxic effects of
high level recombinant protein accumulation (Joensuu et al., 2014). This idea can be
applied to co-expression of unfused, low accumulating proteins with PB-inducing
fusions. This can also be done by addition of an ER retrieval signal (KDEL/HDEL) to
maximize the amount of ER-retrieved proteins since PB formation initiates in the ER.
Indeed, co-expression of EPO with ELP- and HFBI- PBs-inducing fusions showed an
increase in EPO accumulation levels in both cases, with HFBI-induced PBs being more
effective and increasing EPO levels up to three-fold. Similarly, co-expression of IL-10
with HFBI a PB-inducing fusion increased IL-10 accumulation levels almost up to threefold (Chapter 2).
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In this study I co-expressed EPO with a PB-inducing Zera fusion and unlike previous
results with ELP- and HFBI-induced PBs, I did not observe an increase in EPO
accumulation levels. I hypothesize that the physico-chemical properties of Zera prevent
efficient integration of EPO molecules into the lumen of Zera-induced PBs, similar to
what was observed with the co-expression of GFP and Zera. Co-expression experiments
by using PB induction seem to be more efficient by using HFBI or ELP compared to the
Zera fusion tag.

4.3.3

Proteins can be targeted to different PBs

I found that ELP and HFBI fusion proteins co-localize to the same PBs while these
protein fusions do not co-localise with zera fusions. The mechanism by which ELP,
HFBI and Zera fusion tags induce the formation of separate PBs is not understood.
Considering that Zera-fused proteins accumulate in the ER and form PBs without
addition of the conventional ER retrieval signal suggests the possibility of Zera PBs
originating from separate ER subdomains (Lynes and Simmen, 2011; Staehelin, 1997).
Several previous reports of seed storage proteins also have shown the possibility of the
formation of prolamin and globulin-like glutelins on separate subdomains of the ER
(Choi et al., 2000; Hamada et al., 2003a; Hamada et al., 2003b).
It is also possible that the reason behind the formation of Zera PBs separate from ELP
and HFBI PBs might lie within the physico-chemical properties of the Zera molecules
and their very strong affinity towards one another. Zera is a derivative of gamma zein
which belongs to a family of maize seed storage proteins called prolamins. Prolamins are
known to induce PBs by forming large aggregates in the ER due to their hydrophobicity
and disulfide bond formation. It was suggested that these prolamin-induced aggregates
are excluded from transport to the Golgi complex by COP-II vesicles, due to their large
size and therefore induce PB formation (Kawagoe et al., 2005; Pompa and Vitale, 2006;
Vitale and Ceriotti, 2004). The hydrophobic region of Zera molecules is shown to enable
lateral protein-protein interactions, which result in the sticklike alignment of Zera
molecules. This structure is additionally stabilized by intermolecular disulfide bonds
formed between cysteine residues (Llop-Tous et al., 2010). All of these features
contribute to PB formation and simultaneously prevent the integration of other proteins
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into the core of Zera PBs. For instance, Llop-Tous et al. have shown the possibility of
targeting GFP into the core of Zera-induced PBs only by its fusion to a Zera fusion tag
(Llop-Tous et al., 2010). Therefore, the affinity of Zera molecules might prevent the
integration of ELP- or HFBI-fused proteins to Zera PBs as well. This feature of these
three fusion tags can potentially be used for simultaneous expression of different proteins
in vivo and their targeting into the same or separate PBs based on our preference,
especially since Zera, ELP and HFBI can be isolated and purified by different
purification strategies (Linder et al., 2001; Torrent et al., 2009b; Urry and Parker, 2002).

4.3.4

Protein bodies remain part of the ER and communicate with
one another

The mechanism behind PB formation and maturation is complex and unclear. Several
assumptions have been made regarding the fate of PBs depending on their seed- or leafbased origins (Chapter 2). PBs were originally found as storage organelles in plant seeds,
but have also been induced in plant leaves and other eukaryotic species (Shewry and
Halford, 2002; Torrent et al., 2009a). PB formation in seeds initiates in the ER lumen and
depending on the plant species they might remain within the lumen of the rough ER as
dense aggregates or bud off the ER, bypass the Golgi apparatus and be absorbed by
protein storage vacuoles (Galili, 2004; Khan et al., 2012; Lending and Larkins, 1989;
Müntz and Shutov, 2002).
Two major assumptions were made regarding fusion tag-induced PBs in leaves. Zerainduced PBs are believed to originate from the ER, go through maturation and remain as
part of the ER (Llop-Tous et al., 2010; Torrent et al., 2009a). This is based on the
morphological studies of Zera PBs by electron microscopy in which an ER-membrane
was observed surrounding PBs at 7dpi (Llop-Tous et al., 2010). On the other hand, ELPand HFBI-induced PBs were suggested to bud off the ER while surrounded with an ER
membrane and become terminally stored within the cytoplasmic space. This assumption
was made based on the observation of membranes studded with ribosomes surrounding
ELP and HFBI PBs, that PBs did not appear to be connected with the ER in electron
microscopy micrographs, and because they were seen to be mobile and move along the
actin cytoskeleton (Conley et al., 2009b; Joensuu et al., 2010a). In the same study by
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Conley et al. (2009b) a modified GFP-ELP with N-glycosylation sites was shown to
produce PBs and to be fully susceptible to digestion by peptide N-glycosidase F and
endoglycosidase H, confirming the glycosylation pattern of typical ER-retained
glycoproteins. Moreover, co-expression of this construct with a Golgi marker did not
show any co-localization, which indicates that GFP did not proceed to the Golgi
apparatus, and that the PBs did not originate in the Golgi. Conley et al. (2009b) also
showed the recovery of GFP into ELP-induced PBs upon bleaching in FRAP
experiments, although the reason for the recovery was not clear and was attributed to
either trafficking from other PBs or synthesis by ribosomes found on the PB membrane.
In this chapter I have shown that all three types of fusion-tag-induced PBs were
surrounded by a membrane originating in the ER, therefore providing proof for the ER
origin of PBs. I have shown, for the first time, by using a FRAP technique based on
photoconversion of GFP, the trafficking of proteins between PBs in ELP- and HFBIinduced PBs separately. I have also shown that trafficking of PBs happens via the ER.
Based on these observations I propose that ELP and HFBI PBs form and remain within
the ER. I also believe that PBs are not inert storage organelles as they actively exchange
content with other PBs and the ER.

4.4 Conclusion
The main objectives of this study were to understand and compare the similarities and
differences of PBs induced by Zera, ELP and HFBI fusion tags in leaves. My results
confirmed the ER origin of all three fusion-tag-induced PBs. I have shown that Zerafused proteins do not co-localize with ELP- or HFBI-fused proteins into the same PBs,
while ELP and HFBI-fused proteins appeared in the same PBs. I used the GFP
photoconversion approach to track the movement of protein between PBs in vivo for the
first time, and my results confirmed that ELP- or HFBI-induced PBs are not terminally
stored cytosolic organelles, and that ELP and HFBI PBs form and remain part of the ER
and communicate with one another via the ER.
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4.5 Experimental procedure
4.5.1

Construct design and cloning

Secretory GFP, GFP, GFP-ELP (Conley et al., 2009b), GFP-HFBI (Joensuu et al.,
2010a), RFP-HFBI, and RFP-ELP (Chapter 2) plant expression vectors were previously
published. Zera-DsRed, and GFP-SQS were generously provided by Dr. Dolors Ludevid
(Joseph et al., 2012).

4.5.2

Transient expression in N. benthamiana leaves

N. benthamiana plants were grown at 22˚C with a 16 hour photoperiod at a light density
of 110 µmol m-2 s-1 for 7 weeks before infiltration. Plants were watered with the water
soluble fertilizer (N:P:K = 20:8:20) at 0.25 g/L (Plant Products, Brampton, ON, Canada).
Agrobacterium tumefaciens cultures were prepared as previously described (Chapter 2).

4.5.3

Tissue sampling and protein extraction

N. benthamiana leaf samples were collected at 4 dpi. Four leaf discs were collected from
three biological replicates per treatment. Protein extraction and total soluble protein
quantification was performed as previously described (Conley et al., 2009b).

4.5.4

Recombinant protein quantification

Quantification of EPO was performed by sandwich ELISA as previously described
(Conley et al., 2009c). Four biological replicates were quantified per treatment. N.
benthamiana leaf tissue infiltrated with p19 was used as control.

4.5.5

Confocal microscopy and image analysis

To visualize the leaf samples, the abaxial epidermal cells were imaged with a Leica TCS
SP2 CLSM. GFP was imaged by excitation with a 488 nm argon laser and detection
between 500-525 nm. RFP and DsRed were imaged by excitation with 543 nm He/Ne
laser and detection between 553-630 nm and 550-600, respectively.
All photoconversion experiments were performed with a Zeiss LSM 510 confocal
microscope. A 405 nm laser (50 mW at 100% power setting) was used for
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photoconversion. PB photoconversion was performed as described in Chapter 3 by using
20-40% of the laser power with 30-40 iterations. Green-state GFP was imaged by
excitation at 488 nm and detection between 500-525 nm, whereas red-state GFP was
excited by 543 nm laser and detected at 580-640 nm. To visualize the movement of
proteins in vivo, multiple iterations with time intervals were used to allow trafficking of
new GFP into the region of irradiation. Images were processed with the Zeiss Zen
software 2009. Z-stack confocal images were used to generate 3D images and videos by
using Imaris® software (version 7.6.1, Bitplane AG, Switzerland).
In co-expression experiments, all images were acquired in the sequential mode to avoid
crosstalk between the fluorescent channels. All images were acquired at 4 dpi.

4.5.6

Statistical analysis

Minitab Express™ software (Minitab Inc., PA, USA) was used to perform the statistical
analysis. Kolmogorov-Smirnov test was used to confirm the normal distribution of the
data. A one-way analysis of variance (one-way ANOVA) was performed followed by
Tukey-Kramer’s test to find the means significantly different from one another (statistical
difference was defined as p < 0.05).

4.6 Appendices
Supplementary Movie 4. 1 Endoplasmic reticulum-targeted GFP is sequestered into
Zera induced PBs.
Z-stack images of cells co-expressing ER-targeted GFP and Zera-DsRed were acquired
by confocal microscopy and assembled into 4D illustration using the Imaris software.
ER-targeted GFP was sequestered to Zera-induced PBs and also highlighted the ER. Zera
PBs were visible in the red channel. Simultaneous visualization of both green and red
channels showed that ER-targeted GFP surrounded Zera-DsRed PBs. The signals in
green and red channels were detected with the Imaris software and highlighted to show
the accurate localization of each signal. Z-stack images were acquired in sequential
mode. Bar, 5 µm.
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Supplementary Movie 4. 2 Co-expression of HFBI- and Zera-fused fluorescent
proteins.
Co-expression of GFP-HFBI and Zera-DsRed induced the formation of separate PBs.
GFP-HFBI PBs were visualized in the green channel and Zera-DsRed were detected in
the red channel. Simultaneous visualization of both channels showed HFBI and Zera PBs
as separate PBs. Z-stack images were acquired by confocal microscopy and used for 4D
illustrations. Green and red signals were detected and highlighted with the Imaris
software to show the accurate localization of PBs. Z-stack images were acquired in
sequential mode. Bar, 5 µm.
Supplementary Movie 4. 3 Co-expression of ELP- and Zera-fused fluorescent
proteins.
Co-expression of GFP-ELP and Zera-DsRed induced the formation of separate PBs.
GFP-ELP PBs were visualized in the green channel and Zera-DsRed were detected in the
red channel. Simultaneous visualization of both channels showed HFBI and Zera PBs as
separate PBs. Z-stack images were acquired by confocal microscopy and used for 4D
illustrations. Green and red signals were detected and highlighted with the Imaris
software to show the accurate localization of PBs. Z-stack images were acquired in
sequential mode. Bar changes between 3-10 µm depending on different magnifications.
Supplementary Movie 4. 4 Trafficking of proteins between GFP-HFBI-induced
protein bodies.
Time-lapse confocal imaging represents the photoconversion and trafficking of GFPHFBI between PBs. The yellow circle represents the region of irradiation (ROI-1) which
was irradiated with 405 nm laser at 20% of laser power and 40 iterations every 3 minutes.
The white rectangular and square boxes represent the control regions described in Figure
4. Photoconverted GFP-HFBI (red state) can be seen in the red channel. Green channel
represents the GFP-HFBI. Simultaneous photoconversion of the GFP-HFBI from green
to red can be easily seen in the merge channel. Bar, 10 µm.
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Supplementary Movie 4. 5 GFP-HFBI traffics to distant protein bodies via the
endoplasmic reticulum.
GFP-HFBI-induced PBs are shown approximately 1 hour post-photoconversion. The
irradiated PBs were detected with the Imaris software and highlighted with the yellow
spheres. Green channel represents the GFP-HFBI. Red channel shows photoconverted
GFP-HFBI (red-state). Bar, 10 µm.
Supplementary Movie 4. 6 Trafficking of proteins between GFP-ELP-induced
protein bodies.
Time-lapse confocal imaging represents the photoconversion and trafficking of GFP-ELP
between PBs. The yellow circle represents the region of irradiation (ROI-1) which was
irradiated with 405 nm laser at 40% of laser power and 30 iterations every 2.30 minutes.
The white rectangular and square boxes represent the control regions described in Figure
4.6. Photoconverted GFP-ELP (red state) can be seen in the red channel. Green channel
represents the GFP-HFBI. Simultaneous photoconversion of the GFP-ELP from green to
red can be easily seen in the merge channel. Bar, 10 µm.
Supplementary Movie 4. 7 GFP-ELP traffics to distant protein bodies via the
endoplasmic reticulum.
GFP-ELP-induced PBs are shown approximately 45 minutes post-photoconversion. The
irradiated region within the PB was detected with the Imaris software and highlighted
with a yellow sphere. Green channel represents the GFP-ELP. Red channel shows
photoconverted GFP-ELP (red-state). Bar, 10 µm.
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General Discussion
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Plants are on their way to becoming a major platform for production of recombinant
proteins since they offer exclusive advantages compared to traditional expression systems
such as microbial, yeast, insect or mammalian cell cultures. These advantages include
post-translational modifications that allow proper folding and assembly of complex
proteins, rapid scalability, and the absence of human pathogens (Conley et al., 2011;
Twyman et al., 2013). Meanwhile, the low accumulation levels of foreign recombinant
proteins in plants have remained the most challenging problem to be addressed (Ahmad
et al., 2010).
A critical factor determining the final yield of recombinant proteins in plants is their
subcellular destination since targeting to appropriate compartments within the cell affects
the structure and stability of heterologous proteins (Streatfield, 2007). Targeting to
organelles such as chloroplasts, PSVs, or PBs was proposed as a strategy to avoid the
exposure of foreign protein to the host’s proteases, and also to protect the host against the
potential harmful effects of high accumulation levels of the foreign protein (Benchabane
et al., 2008; Conley et al., 2009; Joensuu et al., 2010; Torrent et al., 2009). PBs are ideal
organelles for heterologous protein targeting since they efficiently serve both of these
purposes and also offer other advantages. Being ER-derived organelles, PBs contain low
amounts of proteases, which provides a protective environment for foreign proteins, have
high chaperone content, which helps with folding and assembly of recombinant proteins,
and are contained within a membrane that eliminates the potential toxic effects of highly
accumulated foreign proteins in cells (Desai et al., 2010; Joensuu et al., 2010).
Although PBs are naturally found in plant seeds, it is also possible to induce PB
formation in plant leaves, for instance by addition of Zera, ELP or HFBI fusion tags to
the protein of interest (Conley et al., 2011). The mechanism of PB formation and the role
of fusion tags in PB induction are not well understood. The purpose of this study was to
investigate the driving forces involved in this process.
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5.1 A working model for PB formation
5.1.1

PB formation initiates upon reaching a threshold level

In this thesis, recombinant protein accumulation levels and simultaneous monitoring of
the cells for PB formation suggested that a recombinant protein threshold level of 0.2%
of TSP is required for PB formation as shown in a conceptual model in Figure 5.1. This
observation was based on transient expression of fluorescent proteins (GFP, GFP-ELP,
GFP-HFBI) followed by confocal microscopy, as well as non-fluorescent proteins
(xyn11A, xyn11A-HFBI, and xyn10A) and subsequent immunocytochemistry in N.
benthamiana leaves (Chapter 2, Figure 2.3, and 2.5). These results are in agreement with
the threshold level previously observed for PB formation (at 0.2% of TSP) by expression
of GFP, GFP-ELP and GFP-HFBI in transgenic tobacco leaves (Gutiérrez et al., 2013).
It is important to note that although the presence of fusion tags is not necessary for PB
formation, their presence affects the distribution pattern and size of PBs (Chapter 2,
Figure 2.3). This can be due to the affinity of fusion tags towards one another, which
assists with aggregate formation. Indeed, all three types of fusion tags share a common
important property: the availability of hydrophobic regions, which enables fusion tags
and their fusion partners to self-assemble into aggregates and therefore facilitate the
process of PB formation (Kogan et al., 2002; Linder, 2009; Llop-Tous et al., 2010; Miao
et al., 2003).
Once PBs start forming, they grow over time (Figure 5.1b). This is based on the
observation of GFP-ELP- and GFP-HFBI-induced PBs from 3 to 5 dpi (Chapter 2, Figure
2.2). A similar observation was made for the size of Zera-ECFP-induced PBs from 2 to
10 dpi (Llop-Tous et al., 2010). In all cases, PB size growth was accompanied by an
increase in accumulation levels of the respective recombinant proteins.

5.1.2

Proteins are sequestered passively into PBs

A previous study of ELP-induced PBs showed the co-localization of the ER chaperone
BiP in ELP-induced PBs (Conley et al., 2009), and a proteomic study of Zera-induced PBs
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Figure 5. 1 A working model of protein body formation and development.
(a) Proteins are synthesized on the rough ER by ribosomes and transferred into the ER
lumen co-translationally. PBs form upon high concentrations of the recombinant proteins
in the ER lumen. High concentration of proteins is represented by several GFP-HFBI
molecules in an area. Once PBs form, they grow in size over time. (b) Co-expression of
high value recombinant proteins (in this case EPO) with GFP-HFBI results in passive
sequestration of EPO molecules into GFP-HFBI-induced PBs. (c) After reaching their
final size, PBs remain connected with the ER and exchange their content with other PBs
via the ER. In this example, GFP-HFBI photoconverts to red-state GFP-HFBI upon
irradiation. Photoconverted proteins move from one PB to another through the ER. (d)
Co-localization of green- and red-state GFP in the same PB is shown as yellow.
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also showed the presence of the ER chaperones BiP, calnexin and calreticulin in Zera PBs
(Joseph et al., 2012).
The results presented in this work confirm the sequestration into PBs of several proteins
targeted to the secretory pathway with a signal peptide. For instance, secretory GFP and
ER-targeted GFP both were sequestered into RFP-ELP-, RFP-HFBI-, xyn11A-, and
xyn11A-HFBI-induced PBs upon co-expression (Chapter 2, Figure 2.4 and 2.6).
Therefore, co-expression of valuable and low-accumulating proteins such as EPO and IL10 with PB-inducing proteins such as GFP-HFBI was proposed as a strategy to increase
the accumulation levels of low accumulating proteins (Chapter 2, Figure 2.7). As shown
in figure 5.1b, EPO molecules are sequestered into the core of GFP-HFBI-induced PBs
where they are prevented from progressing through the secretory pathway, and over time,
more recombinant protein accumulates in PBs. This strategy is important for two reasons;
it helps to increase the accumulation levels of difficult-to-express recombinant proteins,
and eliminates the need for the addition of fusion tags which might affect the proper
folding and activity of the protein of interest.
Although co-expression of EPO and IL-10 with GFP-ELP and GFP-HFBI increased their
yield, co-expression with Zera-DsRed did not help with increasing accumulation levels
(Chapter 4, Figure 4.2). This is attributed to the strong affinity of Zera molecules to one
another, which results in a condensed and stick-like alignment of Zera molecules while
forming protein aggregates, as described by Llop-Tous et. al. (2010), and therefore
excluding other molecules from the core of PBs. This was also confirmed with coexpression of secretory GFP or ER-targeted GFP with Zera PBs in which the GFP signal
localized to the periphery of PBs and not in their core (Chapter 4, Figure 4.1).
A patent application based on the co-expression technology using GFP-HFBI as a PBinducing factor, was recently filed for the production of foreign recombinant proteins
vulnerable to the intracellular and extracellular proteolytic activity of proteases (Joensuu
et al., 2014).
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5.1.3

ER is the initiation point and the final destination of PBs

Previous studies on PBs have interpreted the subcellular localization of PBs differently.
Zera-induced PBs were described as highly dense aggregates, which remain connected in
the lumen of the ER rather than forming independent organelles (Llop-Tous et al., 2010;
Torrent et al., 2009). Alternatively, ELP- and HFBI-induced PBs were described as
terminally-stored storage organelles, which bud off the ER and are highly mobile in the
cytosol (Conley et al., 2009; Joensuu et al., 2010). Conley et al. (2009) conducted FRAP
experiments and found that fluorescence of the irradiated PB recovered within minutes
after irradiation, and interpreted fluorescence recovery as due either to protein synthesis
by ribosomes available on the PB membrane, or to trafficking of GFP from neighboring
PBs into the irradiated area.
In this study I investigated whether ELP or HFBI PBs bud off the ER and become
terminally stored cytosolic organelles or remain connected with the ER network. To
address this question, a novel technique based on photoconversion of EGFP without
requirement of additional treatments (e.g. oxygen scavengers) was described for the first
time in this work. First, the ability of EGFP photoconversion from green state to red state
was confirmed in vitro (Chapter 3, Figure 3.2). The photoconversion of EGFP was also
shown to be irreversible. The technique was then tested on a range of different model
organisms including tobacco suspension cell culture, N. benthamiana, Drosophila and rat
cells, and proved functional for studying protein trafficking in vivo (Chapter 3, Figure
3.3, and 3.4). Considering the popularity of EGFP as a fluorescent protein marker in cell
and molecular biology labs, and its widespread availability in different transgenic lines
among several organisms, the ability to photoconvert this protein from green to red
provides a valuable new tool to study protein trafficking in vivo without requirement of
special treatments.
EGFP photoconversion was then tested on ELP- and HFBI-induced PBs. This technique
allowed me to observe protein trafficking out of, and into, the irradiated PBs in vivo
(Chapter 4, Figures 4.5 and 4.6). Results from photoconversion experiments of ELP and
HFBI PBs suggested that these PBs are not terminally stored cytosolic organelles. In both
cases irradiated proteins within PBs were first transferred to surrounding PBs, and then to
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distant PBs within the cell (Figure 5.1c-d). All the photoconverted PBs were shown to be
linked to each other through the ER (Chapter 4, Figure 4.7). Fluorescence recovery of
irradiated PBs appears to be due to trafficking of GFP from surrounding PBs, although
the role of ribosomes located on the PB membrane in synthesizing and transferring new
protein to PBs cannot yet be ruled out.

5.2 Future prospects
It is not fully clear whether high accumulation of proteins causes the formation of PBs or
if the formation of PBs is responsible for accumulation of high amounts of recombinant
proteins. Understanding the mechanism of PB formation will help us to use this
technology for increasing the yield of foreign proteins from plant expression systems
which is a necessary requirement for developing plants as one of the major recombinant
protein production platforms (Gutiérrez and Menassa, 2014).
The purpose of this thesis was to investigate the mechanism of PB formation and the
factors involved in this process. I showed that PB formation is dependent on recombinant
protein accumulation levels, and influenced by the addition of fusion tags. Co-expressed
proteins targeted to the secretory pathway were passively sequestered into PBs, although
localization of proteins targeted to the lumen of Zera PBs was different from their
localization in ELP or HFBI PBs.
The differences between the fusion tags and how they direct their fused protein to PBs
need further investigation. Zera fusion tag does not require an ER retrieval signal to
accumulate in the ER and form PBs unlike ELP and HFBI (Conley et al., 2012). I
showed that Zera-induced PBs did not co-localize with either ELP- or HFBI-induced
PBs. I also showed that all three types of PBs had ER origins. This behavior of Zera PBs
is attributed to the strong affinity of Zera molecules to assemble together and avoid
integration of other molecules. The possibility of Zera-induced PBs originating from a
different subdomain of the ER compared to ELP- or HFBI-induced PBs has yet to be
assessed, for instance by co-expression with ER subdomain-specific proteins, several of
which are described by Lynes and Simmen (2011) and Stefano et al. (2014). Although
PBs induced by fusion tags show differences, this feature might be useful for
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simultaneous expression of different proteins in vivo and their targeting into the same or
separate PBs, especially since Zera, ELP and HFBI can be isolated and purified by
different purification strategies.
It is yet to be assessed if Zera PBs exchange their content with other PBs and if they use
the ER for protein trafficking between PBs in a similar pattern as ELP and HFBI PBs.
This can be answered by photoconversion experiments using an EGFP-Zera fusion. Also,
the role of de novo protein synthesis by ribosomes attached to the PB membrane of Zera-,
ELP- and HFBI-induced PBs needs to be studied. This question can be addressed by a
photoconversion-based FRAP experiment in the presence and absence of an inhibitor of
protein synthesis (e.g. cycloheximide), in which fluorescence recovery is measured.
In conclusion, induction of PB formation enables the storage of high amounts of
recombinant proteins in the limited intracellular space without imposing excessive stress
to the ER, and may be a coping mechanism that eukaryotic cells have evolved to prevent
ER stress and cell death. PBs work as extensions of the ER and provide sufficient space
for accumulation of more protein. In this thesis, I tried to understand the controlling
factors in charge of PB formation. I believe understanding this process will enable us to
efficiently challenge the production bottleneck of low recombinant protein accumulation
levels in plants especially leaf-based expression systems.
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